<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>00253 Mid Day Module (Pharma-2) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Mid Day Module
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">50</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 3863,
    "choices": [
      {
        "id": 15431,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pheniramine</span></span></span></p>"
      },
      {
        "id": 15432,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Promethazine</span></span></span></p>"
      },
      {
        "id": 15433,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dimehydrinate</span></span></span></p>"
      },
      {
        "id": 15434,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cetirizine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A highway truck driver has profuse rhinorrhea and sneezing. Which amongst the following drugs would you prescribe him? </span></span></span></p>",
    "unique_key": "Q7222713",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672820,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Cetirizine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cetirizine</strong> is a <strong>second-generation antihistamine</strong> that is <strong>effective in relieving symptoms of allergic rhinitis,</strong> such as <strong>profuse rhinorrhea</strong> and <strong>sneezing</strong>, without causing significant <strong>sedation</strong>. It is preferred for patients who need to <strong>maintain alertness</strong> and <strong>cognitive function,</strong> such as a <strong>highway truck driver</strong>, because it <strong>crosses the blood-brain barrier </strong>to a <strong>lesser extent than first-generation antihistamines</strong>, resulting in <strong>minimal sedative effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Pheniramine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Pheniramine is a <strong>first-generation antihistamine</strong> that can effectively <strong>relieve allergic symptoms</strong> but is known to <strong>cause sedation as a side effect</strong>, which can impair driving ability and alertness.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Promethazine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Promethazine is another <strong>first-generation antihistamine</strong> with <strong>strong sedative properties,</strong> making it unsuitable for individuals who need to remain alert, such as drivers.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Dimehydrinate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Dimehydrinate is <strong>primarily used to prevent and treat motion sickness </strong>rather than <strong>allergic symptoms</strong>. It also has <strong>sedative effects</strong>, making it inappropriate for someone who must stay awake and alert while driving.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to understand the importance of <strong>selecting appropriate medications</strong> for patients with <strong>allergic symptoms</strong>, taking into consideration their <strong>daily activities</strong> and the <strong>need for alertness.</strong> In this context, <strong>second-generation antihistamines</strong> like <strong>cetirizine</strong> are preferred for individuals who <strong>require minimal impact</strong> on their <strong>cognitive function and alertness</strong>, such as those <strong>operating vehicles</strong> or <strong>heavy machinery.</strong></span></span></span></p>",
    "correct_choice_id": 15434,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3899,
    "choices": [
      {
        "id": 15575,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TNF antagonist</span></span></span></p>"
      },
      {
        "id": 15576,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-1 antagonist</span></span></span></p>"
      },
      {
        "id": 15577,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-2 antagonist</span></span></span></p>"
      },
      {
        "id": 15578,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-6 antagonist</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A new biological therapy, Anakinra has been developed for treatment of Rheumatoid Arthritis. What is the mechanism of action of anakinra?</span></span></span></p>",
    "unique_key": "Q5083466",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672832,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) IL-1 antagonist</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anakinra </strong>is a <strong>biological therapy </strong>used in the <strong>treatment of rheumatoid arthritis </strong>and <strong>other inflammatory conditions</strong>. Its <strong>mechanism of action is as an interleukin-1 </strong>(IL-1) <strong>antagonist</strong>. <strong>Anakinra </strong>works by <strong>competitively inhibiting the binding of IL-1 </strong>to its <strong>receptor</strong>, thereby <strong>blocking the biological activity of IL-1</strong>, a <strong>cytokine </strong>that plays a key role in <strong>causing inflammation </strong>and <strong>tissue damage </strong>in <strong>rheumatoid arthritis</strong>. By <strong>inhibiting IL-1</strong>, <strong>anakinra reduces inflammation</strong>, <strong>decreases joint destruction</strong>, and improves symptoms in patients with rheumatoid arthritis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. TNF antagonist:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect. <strong>TNF antagonists </strong>are a <strong>class of biologics </strong>that include <strong>drugs such as infliximab</strong>, <strong>etanercept</strong>, and <strong>adalimumab</strong>. They work by inhibiting the action of tumor necrosis factor-alpha (TNF-alpha), not IL-1.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. IL-2 antagonist:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect. <strong>IL-2 antagonists</strong>, such as <strong>basiliximab and daclizumab</strong>, are used primarily to <strong>prevent rejection </strong>in <strong>organ transplantation </strong>by <strong>inhibiting the action of interleukin-2 </strong>(IL-2), which is different from the mechanism of action of anakinra.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. IL-6 antagonist:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is incorrect. <strong>IL-6 antagonists</strong>, such as <strong>tocilizumab and sarilumab</strong>, are used in the <strong>treatment of rheumatoid arthritis </strong>by <strong>inhibiting the action of interleukin-6 </strong>(IL-6), a different pathway from that targeted by anakinra.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational goal is to <strong>understand the specific mechanism of action of anakinra </strong>in the <strong>treatment of rheumatoid arthritis</strong>. <strong>Recognizing anakinra </strong>as an <strong>IL-1 antagonist </strong>is crucial for understanding its <strong>role in managing inflammation</strong> and <strong>joint damage</strong> in patients with <strong>rheumatoid arthritis, </strong>highlighting the importance of targeted biological therapies in modulating specific pathways involved in the disease process.</span></span></span></p>",
    "correct_choice_id": 15576,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3322,
    "choices": [
      {
        "id": 13267,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></span></span></p>"
      },
      {
        "id": 13268,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropicamide</span></span></span></p>"
      },
      {
        "id": 13269,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyclopentolate</span></span></span></p>"
      },
      {
        "id": 13270,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Homatropine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the shortest acting mydriatic drug? </span></span></span></p>",
    "unique_key": "Q5666385",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672861,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Tropicamide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropicamide is an <strong>anticholinergic agent </strong>used as a<strong> mydriatic and cycloplegic drug </strong>for eye examinations. It has the <strong>fastest onset</strong> and the<strong> shortest duration of action </strong>compared to the other options, making it the <strong>shortest acting mydriatic.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Atropine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect </strong>because <strong>atropine has a very long duration of action</strong> in the eye, ranging from <strong>7-14 days. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Cyclopentolate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect </strong>as it has a<strong> slower onset of action</strong> and a<strong> longer duration</strong> than <strong>tropicamide. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Homatropine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect </strong>because it <strong>does not </strong>act as<strong> rapidly as tropicamide</strong> and has a <strong>longer duration of action.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tropicamide</strong> is the preferred <strong>mydriatic agen</strong>t for fundus examination due to its<strong> short acting duration</strong>, which is generally around <strong>4-6</strong> <strong>hours</strong>. It is especially <strong>useful over other anticholinergic agents</strong> when a <strong>quick return to normal pupil size</strong> is desired, such as in <strong>outpatient settings.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-122143.jpg\" style=\"height:257px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 13268,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3900,
    "choices": [
      {
        "id": 15579,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acts by inhibiting granulocyte migration in the joint.</span></span></span></p>"
      },
      {
        "id": 15580,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It causes metaphase arrest</span></span></span></p>"
      },
      {
        "id": 15581,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It can result in myopathy as an adverse effect. </span></span></span></p>"
      },
      {
        "id": 15582,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about Colchicine is true? </span></span></span></p>",
    "unique_key": "Q6572089",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672835,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) All of the above</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Colchicine</strong> is a <strong>medication</strong> used primarily in the <strong>treatment of gout and familial Mediterranean fever</strong>. It has <strong>multiple mechanisms </strong>of <strong>action and associated effects,</strong> making all the provided statements true:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Acts by inhibiting granulocyte migration in the joint.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Colchicine</strong> exerts its <strong>anti-inflammatory effects </strong>in part by <strong>inhibiting granulocyte </strong>(a type of white blood cell) <strong>migration </strong>to the<strong> site of inflammation</strong>, which is particularly relevant in the treatment of gout, where granulocytes contribute to the inflammatory response in joints.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. It causes metaphase arrest.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Colchicine binds to tubulin</strong>, a <strong>protein </strong>that is essential for <strong>microtubule formation</strong>. By <strong>inhibiting microtubule polymerization</strong>, <strong>colchicine disrupts mitosis </strong>at the <strong>metaphase stage</strong>, which contributes to its anti-inflammatory effects but also accounts for its toxicity in rapidly dividing cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. It can result in myopathy as an adverse effect.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Colchicine can cause myopathy</strong>, a <strong>muscle disease</strong>, as an <strong>adverse effect,</strong> particularly when <strong>used in high doses </strong>or in patients with renal impairment or when used in combination with other drugs known to increase the risk of myopathy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to understand the <strong>pharmacology of colchicine</strong>, including its <strong>mechanisms of action </strong>and <strong>potential adverse effects</strong>. Recognizing the broad effects of colchicine is crucial for its safe and effective use in clinical practice, especially in the management of gout and for the potential risks associated with its use, such as myopathy.</span></span></span></p>",
    "correct_choice_id": 15582,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3330,
    "choices": [
      {
        "id": 13299,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fesoterodine</span></span></p>"
      },
      {
        "id": 13300,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trospium</span></span></p>"
      },
      {
        "id": 13301,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mirabegron</span></span></p>"
      },
      {
        "id": 13302,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxybutynin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which is the new &beta;3 agonist approved for overactive bladder? </span></span></span></p>",
    "unique_key": "Q6496142",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672813,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Mirabegron</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mirabegron</strong> is a<strong> &beta;3-adrenoceptor agonist </strong>which is a<strong> newer class of drug</strong> used to <strong>treat overactive bladder.</strong> It works by <strong>relaxing the</strong> <strong>smooth muscle of the bladder</strong>, thereby<strong> increasing bladder capacity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Fesoterodine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect</strong>, it is an<strong> antimuscarinic agent </strong>used for <strong>overactive bladder</strong> but <strong>not a &beta;3 agonist. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Trospium</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect</strong>, also an <strong>antimuscarinic</strong>,<strong> not a &beta;3 agonist</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Oxybutynin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>- Incorrect,</strong> this is an<strong> older antimuscarinic drug </strong>used for <strong>overactive bladder</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mirabegron </strong>is the <strong>first &beta;3 agonist</strong> approved for the treatment of <strong>overactive bladder,</strong> offering a <strong>mechanism of action different </strong>from <strong>antimuscarinic agents, </strong>and can be an option for patients who <strong>cannot tolerate </strong>or <strong>do not respond to anticholinergic medications.</strong></span></span></span></p>",
    "correct_choice_id": 13301,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3903,
    "choices": [
      {
        "id": 15591,
        "text": "<p style=\"margin-right:-1px\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colchicine</span></span></p>"
      },
      {
        "id": 15592,
        "text": "<p style=\"margin-right:-1px\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rasburicase </span></span></p>"
      },
      {
        "id": 15593,
        "text": "<p style=\"margin-right:-1px\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allopurinol </span></span></p>"
      },
      {
        "id": 15594,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Probenecid</span></span></p>"
      }
    ],
    "text": "<p style=\"margin-right:-1px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug X shown in the figure represents:</span></span></span></p>\r\n\r\n<p style=\"margin-right:-1px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-1px; text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture11.jpg\" style=\"height:335px; width:300px\" /></p>",
    "unique_key": "Q3063050",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672836,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"margin-right:-1px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Allopurinol </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-1px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-1px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-1px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-1px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Allopurinol </strong>is a <strong>medication that inhibits xanthine oxidase</strong>, an <strong>enzyme</strong> involved in the <strong>purine catabolism pathway </strong>that <strong>converts hypoxanthine to xanthine</strong> and <strong>xanthine to uric acid. </strong>By <strong>inhibiting this enzyme</strong>, <strong>allopurinol decreases</strong> the <strong>production of uric acid,</strong> making it an <strong>effective treatment for chronic gout and hyperuricemia</strong>. The image shows allopurinol (Drug X) as an inhibitor at the step where xanthine oxidase catalyzes the conversion of hypoxanthine to xanthine and xanthine to uric acid.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-1px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-1px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-1px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-1px; text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to understand the <strong>site of action of medications used in the management of gout </strong>and <strong>hyperuricemia</strong>. Recognizing that <strong>allopurinol acts as a xanthine oxidase inhibitor </strong>helps in <strong>understanding how it reduces uric acid levels </strong>and <strong>prevents the formation of urate crystals</strong>, which are responsible for the inflammation and pain associated with gout.</span></span></p>",
    "correct_choice_id": 15593,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3880,
    "choices": [
      {
        "id": 15499,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NSAIDs like indomethacin</span></span></span></p>"
      },
      {
        "id": 15500,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Opioids like morphine</span></span></span></p>"
      },
      {
        "id": 15501,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triptans like sumatriptan</span></span></span></p>"
      },
      {
        "id": 15502,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucocorticoids</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug of choice for aborting the acute attack of severe migraine is?</span></span></span></p>",
    "unique_key": "Q5526893",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672827,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Triptans like sumatriptan</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C:</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">For <strong>acute severe migraine</strong>, the <strong>first line of treatment is sumatriptan </strong>or <strong>other triptans</strong>, which are <strong>selective 5-HT receptor agonists</strong>. <strong>Triptans are effective in aborting a migraine </strong>due to their <strong>ability to cause vasoconstriction of dilated cerebral blood vessels</strong>, i<strong>nhibiting neuropeptide release</strong>, and <strong>blocking pain pathways in the brainstem</strong>.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. NSAIDs like indomethacin:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> &nbsp;While NSAIDs are used for <strong>mild to moderate migraine attacks,</strong> indomethacin can sometimes cause headaches and should be avoided for this condition. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Opioids like morphine: </span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;Opioids are <strong>not the first choice for migraine</strong> as they can <strong>cause medication overuse headaches </strong>and other side effects. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Glucocorticoids:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> &nbsp;These are <strong>not typically used for aborting acute migraine attacks</strong>, although they may be used adjunctively in certain situations.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sumatriptan </strong>and other <strong>triptans are the drugs of choice for the acute treatment of severe migraines</strong>. NSAIDs are preferred for mild to moderate migraines, and various prophylactic medications are available for preventing migraine attacks.</span></span></p>",
    "correct_choice_id": 15501,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3359,
    "choices": [
      {
        "id": 13415,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of TNF alpha</span></span></span></p>"
      },
      {
        "id": 13416,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">COX-2 inhibition</span></span></span></p>"
      },
      {
        "id": 13417,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IL-6 inhibition</span></span></span></p>"
      },
      {
        "id": 13418,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stabilization of mast cells</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Etanercept is a disease-modifying drug used in management of rheumatoid arthritis. What is its mechanism of action? </span></span></p>",
    "unique_key": "Q3190307",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672823,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Inhibition of TNF alpha</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Etanercept </strong>is a <strong>biologic disease-modifying antirheumatic drug </strong>(DMARD) used in the <strong>treatment of rheumatoid arthritis </strong>and other <strong>inflammatory diseases</strong>. Its <strong>mechanism of action </strong>involves the <strong>inhibition of tumor necrosis factor-alpha </strong>(TNF alpha), a <strong>pro-inflammatory cytokine </strong>that plays a key role in the <strong>inflammatory processes of rheumatoid arthritis</strong>. <strong>Etanercept </strong>is a <strong>TNF inhibitor </strong>that <strong>binds to TNF molecules</strong>, preventing them from <strong>interacting with their receptors </strong>on the <strong>surface of cells</strong>. This action effectively reduces inflammation, decreases joint damage, and improves symptoms of rheumatoid arthritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. COX-2 inhibition:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> COX-2 inhibitors are a <strong>class of nonsteroidal anti-inflammatory drugs </strong>(NSAIDs) that specifically <strong>inhibit the cyclooxygenase-2 enzyme</strong>, <strong>reducing pain </strong>and <strong>inflammation. </strong>This mechanism is not related to etanercept&#39;s action.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. IL-6 inhibition:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> IL-6 inhibitors, such as <strong>tocilizumab, target the interleukin-6 </strong>(IL-6) cytokine, another key player in the <strong>inflammatory process of rheumatoid arthritis. </strong>While IL-6 inhibition is a valid therapeutic approach, it is not the mechanism by which etanercept works.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Stabilization of mast cells:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mast cell stabilizers <strong>inhibit the release of histamine </strong>and <strong>other mediators from mast cells</strong>, which are <strong>involved in allergic reactions</strong>, rather than the inflammatory processes central to rheumatoid arthritis. Etanercept does not act by stabilizing mast cells.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-105644.jpg\" style=\"height:671px; width:1000px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational goal is to understand the <strong>specific mechanisms of action of biologic DMARDs, </strong>particularly <strong>etanercept</strong>, in the <strong>management of rheumatoid arthritis</strong>. Recognizing that <strong>etanercept inhibits TNF alpha</strong> highlights the <strong>importance of targeted therapies</strong> in <strong>controlling inflammation</strong> and <strong>preventing joint damage</strong> in <strong>autoimmune diseases. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biological Disease Modifying Anti Rheumatoid Drugs</span></strong></span></span></p>",
    "correct_choice_id": 13415,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3303,
    "choices": [
      {
        "id": 13191,
        "text": "<p><span style=\"font-size:12pt;\">Angle closure glaucoma</span></p>"
      },
      {
        "id": 13192,
        "text": "<p><span style=\"font-size:12pt;\">Asthma</span></p>"
      },
      {
        "id": 13193,
        "text": "<p><span style=\"font-size:12pt;\">Peptic ulcer</span></p>"
      },
      {
        "id": 13194,
        "text": "<p><span style=\"font-size:12pt;\">Urinary incontinence</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">All of the following are indications of antimuscarinic&nbsp;</span><span style=\"font-size:12.0pt;\">drugs except</span><span style=\"color:black;font-size:12.0pt;\">?</span></p>",
    "unique_key": "Q5284000",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672854,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Angle closure glaucoma</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Antimuscarinic drugs</strong> are typically used for their <strong>inhibitory action </strong>on the <strong>parasympathetic nervous system</strong>. They can <strong>relax smooth</strong> <strong>muscle</strong>,<strong> reduce body secretions</strong>, and <strong>decrease gastrointestinal motility, </strong>among other effects.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Angle closure glaucoma </strong>is a<strong> contraindication </strong>for<strong> antimuscarinic drugs </strong>because these medications can further<strong> narrow or close </strong>the already compromised <strong>drainage angles of the eye, </strong>worsening the condition.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B. Asthma:</strong>&nbsp;<strong>Antimuscarinics </strong>are <strong>used </strong>to relieve<strong> bronchospasm </strong>by <strong>inhibiting constrictive parasympathetic </strong>influences on the <strong>bronchial smooth muscle.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Peptic ulcer:</strong>&nbsp; These drugs <strong>reduce gastric acid secretion </strong>and are used to <strong>treat peptic ulcers.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Urinary incontinence:</strong>&nbsp; <strong>Antimuscarinics</strong> can <strong>relax the bladder, </strong>reducing the <strong>urgency and frequency of urination </strong>in overactive bladder<strong>.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In the treatment of various conditions where <strong>parasympathetic inhibition </strong>is <strong>beneficial, antimuscarinic drugs </strong>are indicated; however, they are<strong> contraindicated in angle-closure glaucoma </strong>due to the risk of <strong>exacerbating the condition</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-121431.jpg\" alt=\"\" width=\"1000\" height=\"502\"></span></p>",
    "correct_choice_id": 13191,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3344,
    "choices": [
      {
        "id": 13355,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erection</span></span></span></p>"
      },
      {
        "id": 13356,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ejaculation </span></span></span></p>"
      },
      {
        "id": 13357,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dilation of bronchus </span></span></span></p>"
      },
      {
        "id": 13358,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased cardiac contractility </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscarinic receptor stimulation primarily causes which of the following actions?<strong> </strong></span></span></span></p>",
    "unique_key": "Q2413333",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672815,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Erection</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The muscarinic receptors are a subset of acetylcholine receptors, which are stimulated by the neurotransmitter acetylcholine. Muscarinic receptors are associated with the parasympathetic nervous system, which is responsible for the &#39;rest and digest</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">functions of the body. Here&#39;s the explanation for each option:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erection:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Muscarinic receptor stimulation by the parasympathetic nervous system results in vasodilation and increased blood flow to erectile tissues, leading to an erection. This is an example of a cholinergic action where the neurotransmitter acetylcholine activates muscarinic receptor</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Ejaculation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is primarily a function of the sympathetic nervous system, not muscarinic receptor stimulation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Dilation of bronchus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Muscarinic receptor stimulation actually leads to bronchoconstriction, not dilation. The dilation of bronchi is mediated by the sympathetic nervous system through &beta;2-adrenergic receptors.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Increased cardiac contractility:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is mainly mediated by &beta;1-adrenergic receptors under the influence of the sympathetic nervous system. Muscarinic receptor stimulation can decrease heart rate but does not directly increase contractility.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The parasympathetic nervous system, through muscarinic receptor stimulation, primarily causes erection due to vasodilation in erectile tissues, contrasting with the sympathetic nervous system&#39;s role in ejaculation.</span></span></span></p>",
    "correct_choice_id": 13355,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3280,
    "choices": [
      {
        "id": 13099,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug A in the graph is epinephrine </span></span></span></p>"
      },
      {
        "id": 13100,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The effect on heart rate in graph A can be prevented by anti-muscarinic agents </span></span></span></p>"
      },
      {
        "id": 13101,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug acting on graph B is isoprenaline </span></span></span></p>"
      },
      {
        "id": 13102,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug acting in the graph C is nor-epinephrine </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pharmacological experiment was conducted to study effect of three drugs on heart rate and blood pressure. The following graphs were obtained before and after giving the drug. Which of the following statements is correct? </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture11.jpg\" style=\"height:223px; width:300px\" /></p>",
    "unique_key": "Q1351235",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672845,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) The effect on heart rate in graph A can be prevented by anti-muscarinic agents </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image provided shows <strong>three different graphs labelled A, B, and C</strong>, each depicting<strong> changes in systolic blood pressure (SBP), mean</strong> <strong>blood pressure (MBP), diastolic blood pressure (DBP), and heart rate </strong>before and after the administration of a drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The effect on heart rate in graph A can be prevented by anti-muscarinic agents:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is<strong> correct </strong>because the <strong>reflex bradycardia </strong>seen in response to <strong>increased blood pressure </strong>is mediated by the<strong> parasympathetic nervous system, </strong>which can be <strong>inhibited</strong> by <strong>anti-muscarinic agents</strong>, thereby<strong> preventing the decrease in heart rate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Here&#39;s an analysis of each graph:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Graph A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There&#39;s an <strong>increase in SBP and DBP</strong>, with a marked <strong>increase in MBP</strong>, followed by a<strong> reflex bradycardia (a decrease in heart rate). </strong>This response is consistent with a<strong> drug that causes vasoconstriction</strong>, leading to <strong>increased blood pressure </strong>and a <strong>subsequent reflex slowing of the heart rate </strong>due to<strong> vagal stimulation</strong>. These properties suggest that it is<strong> norepinephrine. </strong>This <strong>reflex decrease </strong>in <strong>heart rate </strong>can be prevented by <strong>anti-muscarinic drugs </strong>like<strong> atropine</strong>. <strong>After giving atropine, same dose of nor-epinephrine </strong>produces <strong>tachycardia </strong>instead of bradycardia because of<strong> its direct action </strong>only. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Graph B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Shows an<strong> increase in SBP and decrease in DBP </strong>with slight <strong>increase in MBP </strong>and a significant <strong>increase in heart rate</strong>. This pattern is typical of<strong> adrenaline</strong>, which has<strong> potent effects on the heart rate</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Graph C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There&#39;s a <strong>substantial increase in SBP </strong>with significant <strong>fall in DBP and MBP, </strong>and significant <strong>increase in heart rate</strong>. This pattern<strong> suggests </strong>that the<strong> drug </strong>is likely to be<strong> isoprenaline. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Drug A in the graph can be epinephrine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is<strong> incorrect </strong>since <strong>epinephrine </strong>usually<strong> increases heart rate </strong>due to its <strong>beta-1</strong> <strong>stimulatory effect.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Option C. The drug acting on graph B is isoprenaline:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>incorrect </strong>because<strong> isoprenaline (also known as isoproterenol)</strong> is a<strong> non-selective beta-adrenergic agonist </strong>that can<strong> increase SBP</strong> but <strong>decrease DBP </strong>and<strong> MBP.</strong> Rather the graph shown is typically present in epinephrine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. The drug acting in graph C is norepinephrine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is<strong> incorrect</strong> because <strong>norepinephrine </strong>primarily<strong> increases SBP,</strong> <strong>DBP and MBP </strong>and cause <strong>reflex tachycardia.</strong> The<strong> graph shown </strong>is typically present in<strong> isoprenaline. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anti-muscarinic agents</strong> can prevent the <strong>reflex bradycardia</strong> induced by <strong>vasoconstrictive drugs </strong>like<strong> norepinephrine </strong>by inhibiting the <strong>parasympathetic nervous system&#39;s</strong> control <strong>over the heart.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Goodman and Gilman 12th/283</span></strong></span></span></p>",
    "correct_choice_id": 13100,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3918,
    "choices": [
      {
        "id": 15651,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TXA2</span></span></span></p>"
      },
      {
        "id": 15652,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LT</span></span></span></p>"
      },
      {
        "id": 15653,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bradykinin</span></span></span></p>"
      },
      {
        "id": 15654,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PGI2</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old patient being treated with low dose aspirin for 6 months presented with rectal bleeding. Inhibition of which of the following substance is likely to responsible for the bleeding?</span></span></p>",
    "unique_key": "Q8108468",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672843,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) TXA2</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A:</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Aspirin&#39;s inhibition</strong> of <strong>thromboxane A2 </strong>(TXA2) is likely responsible for the <strong>patient&#39;s bleeding.</strong> <strong>NSAIDs</strong>, including <strong>aspirin, inhibit the synthesis of prostanoids.</strong> <strong>Aspirin </strong>acts particularly on <strong>platelet COX-1</strong>, preventing the <strong>formation of TXA2</strong>, a <strong>pro-aggregatory agent</strong>. Given that platelets cannot synthesize new enzymes and aspirin&#39;s effects last for the lifespan of the platelet, even low doses can significantly reduce platelet aggregation and consequently increase bleeding risk.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong><u> </u></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. LT:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Leukotrienes </strong>(LT) are <strong>not primarily affected by low-dose aspirin </strong>and are more related to inflammation and bronchoconstriction. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Bradykinin:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;It is <strong>involved in inflammatory responses </strong>and <strong>pain</strong>; aspirin does not significantly affect bradykinin levels. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. PGI2:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Also known as <strong>prostacyclin</strong>, is an <strong>anti-aggregatory prostanoid</strong>. While aspirin does inhibit PGI2, its predominant effect on platelets and the associated bleeding risk is through inhibition of TXA2 synthesis.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>educational goal </strong>is to understand the <strong>mechanism of action </strong>of <strong>aspirin </strong>and its <strong>effects on platelet function</strong>, particularly its <strong>inhibition of thromboxane A2 synthesis</strong>, which <strong>reduces platelet aggregation</strong>. This <strong>antiplatelet effect </strong>is beneficial for <strong>preventing thrombosis </strong>but can also <strong>predispose to bleeding complications</strong>, underscoring the need for careful monitoring of patients on long-term aspirin therapy.</span></span></span></p>",
    "correct_choice_id": 15651,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3873,
    "choices": [
      {
        "id": 15471,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dihydroergotamine</span></span></span></p>"
      },
      {
        "id": 15472,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sumatriptan</span></span></span></p>"
      },
      {
        "id": 15473,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin</span></span></span></p>"
      },
      {
        "id": 15474,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Butorphanol</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After taking some drug for acute attack of migraine, a patient developed nausea and vomiting, He also developed tingling and numbness in the tip of the finger that turned blue. Which of the following is the most likely drug implicated in causing the above findings?</span></span></p>",
    "unique_key": "Q2761746",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672824,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Dihydroergotamine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A:</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The correct answer is <strong>Dihydroergotamine</strong>. This medication is associated with <strong>vasoconstrictive side effects</strong>, which can be significant enough to <strong>cause symptoms such as nausea</strong>, <strong>vomiting</strong>, and <strong>peripheral ischemia</strong>, <strong>leading to tingling</strong>, <strong>numbness</strong>, and a <strong>bluish discoloration</strong> in the <strong>extremities like the tips of the fingers. </strong>This is due to the <strong>reduction in blood flow</strong> that can result from the <strong>vasoconstriction </strong>caused by <strong>ergot alkaloids,</strong> which <strong>dihydroergotamine</strong> is a part of.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Sumatriptan:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">While Sumatriptan is indeed the <strong>drug of choice</strong> (DOC) for <strong>acute migraine attacks,</strong> it is <strong>less likely than dihydroergotamine</strong> to <strong>cause severe vasoconstriction </strong>leading to the symptoms described. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Aspirin:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">As a <strong>non-steroidal anti-inflammatory drug </strong>(NSAID), <strong>aspirin</strong> is used in <strong>mild to moderate migraine attacks</strong> and does not typically cause vasoconstriction or gangrene.<strong> </strong></span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Butorphanol:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;This <strong>opioid</strong> is <strong>used in severe cases </strong>of <strong>migraine</strong> where sumatriptan is not suitable. It does not typically cause the vasoconstriction associated with gangrene.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong><u> </u></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dihydroergotamine,</strong> an <strong>ergot alkaloid</strong>, can cause <strong>severe vasoconstriction</strong> resulting in symptoms such as <strong>nausea, vomiting, tingling, numbness, </strong>and a <strong>bluish discoloration of the extremities</strong> due to <strong>reduced blood flow.</strong> It is contraindicated in patients with peripheral vascular disease and can lead to gangrene.</span></span></p>",
    "correct_choice_id": 15471,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3308,
    "choices": [
      {
        "id": 13211,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in heart rate</span></span></p>"
      },
      {
        "id": 13212,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease in heart rate</span></span></p>"
      },
      {
        "id": 13213,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in mean arterial pressure</span></span></p>"
      },
      {
        "id": 13214,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased renal perfusion and reduced urine output</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient of septic shock was given intravenous nor-epinephrine. The response to this drug is best checked by?</span></span></p>",
    "unique_key": "Q5168986",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672856,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Increase in mean arterial pressure</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the treatment of<strong> septic shock</strong>, the primary therapeutic goal is to <strong>stabilize hemodynamics </strong>and <strong>improve tissue perfusion</strong>. <strong>Nor-epinephrine (norepinephrine) </strong>is a<strong> potent vasopressor </strong>that <strong>increases both systolic and diastolic blood pressure</strong>. It is commonly used to<strong> counteract the vasodilatory effects of septic shock </strong>and help maintain <strong>adequate organ perfusion</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Increase in heart rate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Not the best indicator </strong>for the efficacy of<strong> nor-epinephrine in septic shock</strong>, as the drug may actually lead to a <strong>reflex bradycardia due to increased blood pressure. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Decrease in heart rate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - While <strong>nor-epinephrine </strong>can cause a<strong> reflex decrease in heart rate </strong>due to <strong>increased blood pressure, </strong>it&#39;s<strong> not the primary indicator </strong>of therapeutic response in septic shock. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Decreased renal perfusion and reduced urine output</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - These are<strong> potential adverse effects of nor-epinephrine </strong>due to its <strong>vasoconstrictive action</strong>, <strong>not </strong>indicators of a <strong>positive therapeutic response.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The effectiveness of <strong>nor-epinephrine </strong>in the management of<strong> septic shock </strong>is best<strong> monitored </strong>by an <strong>increase in mean arterial pressure</strong>, aiming to <strong>maintain a mean BP above 70 mm Hg and systolic BP above 90 mm Hg </strong>to ensure <strong>adequate organ perfusion</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Harrison 19<sup>th</sup>/1761</span></strong></span></span></p>",
    "correct_choice_id": 13213,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3356,
    "choices": [
      {
        "id": 13403,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patent ductus arteriosus</span></span></span></p>"
      },
      {
        "id": 13404,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature closure of ductus arteriosus</span></span></span></p>"
      },
      {
        "id": 13405,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patent ductus venosus</span></span></span></p>"
      },
      {
        "id": 13406,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature closure of ductus venosus</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-week pregnant female with polyhydramnios presents with labour pain. She was treated with indomethacin earlier. Which of the following can be likely outcome in the baby if delivery occurs at this time? </span></span></span></p>",
    "unique_key": "Q4502568",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672821,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Premature closure of ductus arteriosus</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Indomethacin</strong>, a <strong>nonsteroidal anti-inflammatory drug </strong>(NSAID), is known to <strong>cause the premature closure of the ductus arteriosus </strong>in the <strong>fetus </strong>when <strong>administered during pregnancy</strong>, particularly in the <strong>third trimester</strong>. The <strong>ductus arteriosus </strong>is a <strong>vital fetal blood vessel </strong>that <strong>connects the pulmonary artery </strong>to the <strong>descending aorta</strong>, <strong>allowing blood to bypass </strong>the <strong>non-functioning fetal lungs</strong>. <strong>Indomethacin inhibits prostaglandin synthesis</strong>, which is necessary for <strong>keeping the ductus arteriosus open</strong>. Therefore, its use in pregnancy, especially close to term, can lead to the premature closure of the ductus arteriosus, potentially resulting in cardiac complications and pulmonary hypertension in the newborn.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Patent ductus arteriosus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This condition occurs when the <strong>ductus arteriosus fails to close after birth</strong>, leading to <strong>abnormal blood flow </strong>between the <strong>aorta and pulmonary artery</strong>. It is not a direct outcome of indomethacin use during pregnancy; rather, indomethacin is used to encourage the closure of a patent ductus arteriosus in the neonatal period.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Patent ductus venosus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>ductus venosus </strong>is a <strong>fetal blood vessel that diverts some blood flow </strong>directly from the <strong>umbilical vein </strong>to the <strong>inferior vena cava</strong>, <strong>bypassing the liver</strong>. A patent ductus venosus after birth is unrelated to indomethacin exposure.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Premature closure of ductus venosus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Like the <strong>patent ductus venosus</strong>, <strong>premature closure </strong>of this <strong>vessel </strong>is <strong>not </strong>a recognized <strong>outcome of indomethacin </strong>use in <strong>pregnancy</strong>. The ductus venosus naturally closes after birth as part of the normal transition from fetal to neonatal circulation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective is to <strong>recognize the potential effects of indomethacin use </strong>during <strong>pregnancy on the fetal cardiovascular system</strong>, specifically the <strong>risk of premature closure </strong>of the <strong>ductus arteriosus</strong>. Understanding the <strong>pharmacological impacts of NSAIDs </strong>on <strong>fetal development </strong>is crucial for <strong>making informed decisions </strong>about <strong>drug use in pregnancy</strong>, highlighting the importance of weighing the benefits against potential risks when managing conditions like polyhydramnios</span></span></span></p>",
    "correct_choice_id": 13404,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3909,
    "choices": [
      {
        "id": 15615,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic tophaceous gout</span></span></span></p>"
      },
      {
        "id": 15616,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paralytic ileus</span></span></span></span></p>"
      },
      {
        "id": 15617,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rheumatoid arthritis</span></span></span></span></p>"
      },
      {
        "id": 15618,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Psoriatic arthritis</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pegloticase is used in treatment of:</span></span></span></span></p>",
    "unique_key": "Q5105522",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672838,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A) Chronic tophaceous gout</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A:</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Pegloticase </strong>is specifically indicated for the <strong>management of chronic tophaceous gout</strong>, a <strong>severe form of gout </strong>where <strong>urate crystals accumulate </strong>in <strong>joints </strong>due to <strong>elevated levels of uric acid in the blood</strong>, leading to the <strong>formation of tophi</strong>. <strong>Pegloticase </strong>works by <strong>converting uric acid into allantoin</strong>, which is <strong>more soluble </strong>and easier for the <strong>body to excrete</strong>. It is a viable option for patients who do not respond to or are unable to take traditional gout medications and who have developed tophi.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Paralytic ileus: </span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;Pegloticase is <strong>not</strong> used for <strong>treating gastrointestinal conditions</strong> like paralytic ileus. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Rheumatoid arthritis: </span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;While also a <strong>form of arthritis,</strong> rheumatoid arthritis is not treated with pegloticase. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Psoriatic arthritis</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: This <strong>type of arthritis</strong>, associated with <strong>psoriasis</strong>, is not an indication for pegloticase therapy.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pegloticase </strong>is an <strong>enzyme therapy </strong>used in the <strong>treatment of chronic tophaceous gout</strong>, particularly in patients who have <strong>failed conventional therapy</strong>. It catalyzes the conversion of uric acid to allantoin, facilitating the reduction of uric acid levels in the body.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture4.jpg\" style=\"height:230px; width:340px\" /></span></span></p>",
    "correct_choice_id": 15615,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 25532,
    "choices": [
      {
        "id": 102082,
        "text": "<p><span style=\"font-size:12.0pt;\">Tachyphylaxis</span></p>"
      },
      {
        "id": 102083,
        "text": "<p><span style=\"font-size:12.0pt;\">Biphasic response of epinephrine</span></p>"
      },
      {
        "id": 102084,
        "text": "<p><span style=\"font-size:12.0pt;\">Vasomotor reversal of Dale</span></p>"
      },
      {
        "id": 102085,
        "text": "<p><span style=\"font-size:12.0pt;\">Phentolamine epinephrine coupling</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In a dog blood pressure experiment, a researcher injected phentolamine first followed by epinephrine and the recordings of the effect are shown in the diagram given below. This phenomenon is known as?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/6.jpg\" alt=\"\" width=\"500\" height=\"175\"></span></p>",
    "unique_key": "Q4911950",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672833,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Vasomotor reversal of Dale</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Normally epinephrine produces a biphasic response on blood pressure which is characterized by increase in BP followed by decrease in BP. First increase is due to stimulation of alpha 1 receptors and later on decrease is due to stimulation of beta 2 receptors.</span></li><li><span style=\"font-size:12.0pt;\">However, If alpha blockers like phentolamine are already given and then we administer epinephrine, it causes only exaggerated fall in blood pressure. This is called vasomotor reversal of Dale.</span></li><li><span style=\"font-size:12.0pt;\">If we give same dose of a drug repeatedly and there is decrease in effect of the drug, it is called tachyphylaxis. It is shown by drugs like ephedrine.</span></li><li><span style=\"font-size:12.0pt;\">There is no term like phentolamine epinephrine coupling.</span></li></ul>",
    "correct_choice_id": 102084,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3353,
    "choices": [
      {
        "id": 13391,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blockers</span></span></span></p>"
      },
      {
        "id": 13392,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mannitol</span></span></span></p>"
      },
      {
        "id": 13393,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetazolamide</span></span></span></p>"
      },
      {
        "id": 13394,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandin analogues</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presented with acute glaucoma and painful red eye. Intraocular pressure was 38 mmHg. Slit lamp examination showed aqueous flare and keratic precipitates. Which of the following drugs should not be given in this patient for the control of glaucoma?</span></span></span></p>",
    "unique_key": "Q1335755",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672819,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Prostaglandin analogues</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient given in the question presents with<strong> acute glaucoma a</strong>ccompanied by <strong>uveitis,</strong> as indicated by symptoms like a <strong>painful red</strong> <strong>eye, elevated intraocular pressure (38 mmHg), aqueous flare, and keratic precipitates</strong>.<strong> Uveitis</strong> involves <strong>inflammation of the uveal</strong> <strong>tract of the eye,</strong> which can <strong>complicate</strong> the <strong>management of glaucoma.</strong> The<strong> presence of uveitis</strong> necessitates the <strong>use of medication</strong>s that <strong>lower intraocular pressure</strong> without worsening the<strong> inflammatory component of the disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandin analogues</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (D. Prostaglandin analogues) are generally <strong>contraindicated in cases of glaucoma</strong> with <strong>concurrent uveitis.</strong> Prostaglandin analogues can potentially<strong> exacerbate inflammation within the eye. </strong>These drugs are effective in<strong> lowering intraocular pressure </strong>by<strong> increasing uveoscleral outflow</strong> in<strong> chronic open-angle glaucoma </strong>but may <strong>not</strong> be suitable in the <strong>presence of uveiti</strong>s due to their <strong>potential to increase inflammation.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option Beta blockers</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (A. Beta blockers) <strong>reduce intraocular pressure</strong> by <strong>decreasing </strong>the production of<strong> aqueous humor.</strong> They <strong>do not </strong>directly address <strong>inflammation</strong> but can be used in <strong>conjunction </strong>with <strong>anti-inflammatory treatments.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option Mannitol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (B. Mannitol), an <strong>osmotic diuretic</strong>, can <strong>rapidly reduce intraocular pressure</strong> by <strong>drawing fluid out</strong> of the <strong>eye,</strong> including in <strong>acute settings. </strong>It <strong>does not</strong> worsen the <strong>underlying inflammation.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option Acetazolamide</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (C. Acetazolamide) <strong>reduces aqueous humor production </strong>and, consequently, <strong>ientraocular pressure.</strong> These<strong> does not</strong> worsen<strong> inflammation</strong> and is used as part of a <strong>broader treatment regimen.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>For managing uveitis</strong> specifically,<strong> treatment </strong>often includes <strong>corticosteroids (either topical, periocular, or systemic)</strong> to <strong>reduce</strong> <strong>inflammation and immunosuppressive agent</strong>s in <strong>more severe cases</strong>. It&rsquo;s important to treat <strong>both the inflammation</strong> caused by<strong> uveitis</strong> and the <strong>elevated intraocular pressure to prevent vision loss.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> presence of uveitis </strong>in a patient with<strong> glaucoma </strong>significantly<strong> impacts </strong>the choice of treatment. Understanding the need to <strong>manage</strong> <strong>intraocular pressure </strong>while also addressing<strong> ocular inflammation is crucial.</strong> The goal is to select a treatment regimen that effectively <strong>lowers intraocular pressure without exacerbating uveitis</strong>, highlighting the importance of a comprehensive approach to patient care that considers the complexities introduced by overlapping ocular conditions.</span></span></span></p>",
    "correct_choice_id": 13394,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3890,
    "choices": [
      {
        "id": 15539,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Buspirone</span></span></span></p>"
      },
      {
        "id": 15540,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renzapride</span></span></span></p>"
      },
      {
        "id": 15541,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Granisetron</span></span></span></p>"
      },
      {
        "id": 15542,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoclopramide</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drug acts by stimulation of 5HT4 receptors? </span></span></span></p>",
    "unique_key": "Q8037564",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672831,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Renzapride</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>5HT4 receptors </strong>are <strong>located in the gastrointestinal tract </strong>and are <strong>involved in increasing peristalsis</strong>. <strong>Renzapride </strong>acts as an <strong>agonist at these receptors</strong>, which makes it <strong>useful in the treatment of conditions </strong>like <strong>gastroesophageal reflux disease </strong>(GERD) where enhanced gastrointestinal motility is desired.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong><u> </u></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Buspirone&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">- It is a <strong>5-HT1A agonist </strong>and is <strong>primarily used for the treatment of anxiety</strong>. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Granisetron -&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This is a <strong>5-HT3 receptor antagonist</strong>, which is <strong>indicated for the prevention of chemotherapy-induced nausea </strong>and <strong>vomiting</strong>. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Metoclopramide&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">- It is an <strong>antagonist at D2 receptors </strong>and is used for its <strong>anti-emetic </strong>and <strong>prokinetic properties</strong>.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Renzapride is a 5-HT4 receptor agonist </strong>used to <strong>increase peristalsis in the gastrointestinal tract</strong>. Many <strong>5-HT4 agonists</strong>, useful for <strong>GERD</strong>, <strong>end in &#39;pride&#39; such as cisapride</strong>, <strong>mosapride</strong>, and <strong>prucalopride</strong>. It&#39;s important to note that Tegaserod, another 5-HT4 agonist, was withdrawn due to increased risk of myocardial infarction.</span></span></p>",
    "correct_choice_id": 15540,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3284,
    "choices": [
      {
        "id": 13115,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Closed angle glaucoma</span></span></span></p>"
      },
      {
        "id": 13116,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bradycardia</span></span></span></p>"
      },
      {
        "id": 13117,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cobra bite</span></span></span></p>"
      },
      {
        "id": 13118,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myasthenia gravis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholinomimetic drugs can be used for the treatment of all the following conditions except ?</span></span></span></p>",
    "unique_key": "Q6571315",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672847,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Bradycardia&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinomimetic drugs</strong>, which <strong>mimic the action of acetylcholine</strong>, will actually cause<strong> bradycardia </strong>as an <strong>adverse effect </strong>due to their stimulation of <strong>muscarinic receptors in the heart</strong>. Therefore, they are<strong> not used to treat bradycardia</strong>, where the goal is to<strong> increase heart rate</strong>, not decrease it further.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Correct Usage - Closed angle glaucoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is treated with drugs like <strong>Physostigmine and Pilocarpine to increase aqueous humor outflow</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Correct Usage - For a cobra bite:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; <strong>Neostigmine plus atropine </strong>is used to <strong>counteract the neuromuscular blockade </strong>caused by the <strong>venom</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Correct Usage - In Myasthenia gravis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> drugs such as<strong> Neostigmine </strong>are used to enhance<strong> neuromuscular transmission </strong>by preventing the <strong>breakdown of acetylcholine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additional Uses of Cholinergic Drugs:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alzheimer&rsquo;s disease </strong>treatment with<strong> Donepezil, Rivastigmine, and Galantamine </strong>to <strong>increase acetylcholine </strong>in the brain.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Management of <strong>xerostomia </strong>with drugs like <strong>Cevimeline </strong>to stimulate <strong>salivary gland secretion</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Postoperative urinary retention </strong>and <strong>paralytic ileus </strong>managed with drugs like <strong>Bethanechol and Neostigmine </strong>to stimulate the<strong> bladder detrusor muscle and GI motility</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Antidote for anticholinergic poisoning </strong>with<strong> Physostigmine </strong>to counteract <strong>muscarinic receptor blockade.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cholinomimetic drugs </strong>are <strong>not used </strong>for the treatment of<strong> bradycardia </strong>due to their potential to cause a<strong> decrease in heart rate</strong>. They are, however, useful in treating various other conditions where <strong>increased cholinergic action </strong>is beneficial, such as<strong> closed angle glaucoma, cobra bites, Myasthenia gravis, and Alzheimer&rsquo;s disease.</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-120058.jpg\" style=\"height:425px; width:1000px\" /></span></span></p>",
    "correct_choice_id": 13116,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3905,
    "choices": [
      {
        "id": 15599,
        "text": "<p style=\"margin-right:-1px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colchicine</span></span></span></p>"
      },
      {
        "id": 15600,
        "text": "<p style=\"margin-right:-1px\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rasburicase </span></span></p>"
      },
      {
        "id": 15601,
        "text": "<p style=\"margin-right:-1px\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allopurinol </span></span></p>"
      },
      {
        "id": 15602,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Probenecid</span></span></p>"
      }
    ],
    "text": "<p style=\"margin-right:-1px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug Y shown in figure represents:</span></span></span></p>\r\n\r\n<p style=\"margin-right:-1px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-1px\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture21.jpg\" style=\"height:306px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q4469567",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672837,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"margin-right:-1px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Rasburicase </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-1px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-1px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-1px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Rasburicase </strong>is an <strong>enzyme that catalyzes the oxidation of uric acid to allantoin, </strong>which is a <strong>more soluble </strong>and <strong>easily excreted substance in the urine</strong>. In the <strong>purine catabolism diagram</strong>, <strong>Drug Y facilitates </strong>the <strong>conversion of uric acid to allantoin</strong>, matching the <strong>action of rasburicase</strong>. This is particularly <strong>useful in the management of tumor lysis syndrome</strong>, a condition where <strong>rapid breakdown </strong>of <strong>tumor cells </strong>can <strong>lead to acute hyperuricemia </strong>and <strong>potential renal damage</strong>. Rasburicase helps to quickly lower uric acid levels and prevent such complications.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Colchicine</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: &nbsp;It is <strong>used in the treatment of gout</strong>, not as a urate-lowering agent, but to alleviate inflammation. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Allopurinol: </span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;It works by <strong>inhibiting xanthine oxidase</strong>, thereby <strong>preventing the formation of uric acid from xanthine </strong>and hypoxanthine. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Probenecid:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This <strong>drug acts by increasing the renal excretion of uric acid </strong>but does not directly convert uric acid to allantoin.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong><u> </u></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:14px; margin-right:-1px; text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The goal is to understand the <strong>role of rasburicase </strong>in the <strong>management of hyperuricemia</strong>, especially in the <strong>acute setting of tumor lysis syndrome</strong>. Knowledge of rasburicase&rsquo;s mechanism of action is essential for recognizing its value in lowering elevated uric acid levels quickly to prevent renal damage and other serious complications.</span></span></p>",
    "correct_choice_id": 15600,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3357,
    "choices": [
      {
        "id": 13407,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leflunomide</span></span></span></p>"
      },
      {
        "id": 13408,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Azathioprine</span></span></span></p>"
      },
      {
        "id": 13409,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydroxychloroquine</span></span></span></p>"
      },
      {
        "id": 13410,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methotrexate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following Disease modifying anti- rheumatoid drugs acts by causing extracellular accumulation of adenosine? </span></span></span></p>",
    "unique_key": "Q2159293",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672822,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Methotrexate</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Methotrexate</strong>, although primarily known as an <strong>inhibitor of dihydrofolate reductase </strong>(DHFRase) <strong>enzyme</strong>, <strong>exerts </strong>its <strong>major mechanism of action </strong>in the <strong>treatment of Rheumatoid Arthritis </strong>(RA) by <strong>increasing extracellular adenosine levels</strong>. <strong>Methotrexate </strong>inhibits <strong>enzymes </strong>involved in <strong>de novo purine synthesis</strong>, including <strong>AICAR </strong>(5-aminoimidazole-4-carboxamide ribonucleotide) <strong>transformylase</strong>. This <strong>inhibition leads to the accumulation of AICAR</strong>, which subsequently <strong>inhibits adenosine deaminase</strong>. As a result, adenosine cannot be converted to inosine, leading to an increase in the level of extracellular adenosine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Leflunomide:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Leflunomide is an <strong>inhibitor of dihydroorotate dehydrogenase</strong>, an enzyme involved in the de novo synthesis of pyrimidine. It does not directly affect adenosine levels.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Azathioprine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Azathioprine is a <strong>prodrug that is converted to 6-mercaptopurine </strong>(6-MP), which <strong>inhibits purine synthesis </strong>by <strong>acting as a purine analogue</strong>. It does not directly affect adenosine levels.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hydroxychloroquine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydroxychloroquine <strong>exerts its effects by inhibiting lysosomal acidification</strong>, <strong>antigen presentation</strong>, and <strong>Toll-like receptor signaling</strong>. It does not directly affect adenosine levels.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Methotrexate increases extracellular adenosine levels </strong>by <strong>inhibiting enzymes </strong>involved in <strong>de novo purine synthesis</strong>, which contributes to its <strong>anti-inflammatory effects </strong>in the <strong>treatment of Rheumatoid Arthritis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture1.jpg\" style=\"height:114px; width:300px\" /></span></span></span></p>",
    "correct_choice_id": 13410,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3883,
    "choices": [
      {
        "id": 15511,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Promethazine</span></span></span></p>"
      },
      {
        "id": 15512,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Meclizine</span></span></span></p>"
      },
      {
        "id": 15513,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cinnarizine</span></span></span></p>"
      },
      {
        "id": 15514,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fexofenadine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following antihistamines has minimal or no CNS depressant activity?</span></span></span></p>",
    "unique_key": "Q9247819",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672829,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Fexofenadine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D:</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Fexofenadine </strong>is a <strong>second-generation antihistamine</strong>, which is known for <strong>having minimal to no CNS depressant activity</strong>. <strong>Second-generation antihistamines </strong>are <strong>less likely to cross the blood-brain barrier</strong>, <strong>reducing the risk of sedation </strong>commonly associated with <strong>first-generation antihistamines</strong>.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Promethazine: </span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;A <strong>first-generation antihistamine </strong>with <strong>sedative properties</strong>. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Meclizine</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: &nbsp;Another <strong>first-generation antihistamine </strong>that can <strong>cause sedation</strong>. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Cinnarizine</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: &nbsp;Also a <strong>first-generation antihistamine </strong>with <strong>CNS depressant effects</strong>.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Fexofenadine </strong>is a <strong>second-generation antihistamine </strong>with <strong>minimal to no CNS depressant activity</strong>. It is <strong>selective for the H1 receptor </strong>and <strong>does not </strong>have significant <strong>anticholinergic activity </strong>or additional <strong>anti-allergic mechanisms </strong>beyond <strong>histamine blockade</strong>, unlike <strong>first-generation antihistamines </strong>which can <strong>cause sedation </strong>as they cross the blood-brain barrier.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp; H<sub>1</sub> ANTIHISTAMINES</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-110939.jpg\" style=\"height:528px; width:1000px\" /></span></strong></span></span></p>",
    "correct_choice_id": 15514,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3352,
    "choices": [
      {
        "id": 13387,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">64-year-old female with frequent attacks of migraine</span></span></span></p>"
      },
      {
        "id": 13388,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors </span></span></p>"
      },
      {
        "id": 13389,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">56-year-old male with erectile dysfunction</span></span></span></p>"
      },
      {
        "id": 13390,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">74-year-old male with history of compensated heart failure</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following patients would not benefit from the use of beta blockers? </span></span></p>",
    "unique_key": "Q2391640",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672818,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 56-year-old male with erectile dysfunction</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-blockers</strong> are a <strong>class of medications </strong>that can be used for <strong>various conditions</strong>, including <strong>migraine prophylaxis</strong>, <strong>management of</strong> <strong>hyperthyroid symptoms, and heart failure. </strong>However, they can have <strong>side effects</strong> that <strong>affect sexual function</strong>, making them <strong>potentially</strong> <strong>problematic</strong> for patients <strong>with erectile dysfunction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. 64-year-old female with frequent attacks of migraine:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-blockers</strong> are often used for the<strong> prophylaxis of</strong> <strong>migraines</strong>. They can help <strong>reduce the frequency </strong>and <strong>severity of migraine attacks.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. 35-year-old female with hyperthyroidism and symptomatic tachycardia and tremors:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-blockers</strong> are <strong>useful </strong>in managing symptoms of <strong>hyperthyroidism </strong>such as <strong>tachycardia and tremors </strong>by <strong>blocking the effects</strong> of <strong>excess</strong> t<strong>hyroid hormones on the heart and other tissues.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:-24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. 74-year-old male with history of compensated heart failure:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Certain&nbsp;<strong>beta-blockers </strong>are indicated in the management of <strong>heart failure</strong>. They can i<strong>mprove survival and reduce</strong> the need for<strong> hospitalization</strong> in patients with <strong>heart</strong> <strong>failure, </strong>especially those with a<strong> history of compensated heart failure, </strong>provided they are <strong>carefully selected and dosed.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to understand the <strong>indications and contraindications </strong>for <strong>beta-blocker therapy</strong>. While<strong> beta-blockers are versatile</strong> <strong>medications </strong>with a <strong>broad range of clinical applications</strong>, their<strong> potential side effects, </strong>such as <strong>exacerbating erectile dysfunction</strong>, must be considered when <strong>prescribing these drugs to ensure they align </strong>with the patient&#39;s overall <strong>health status and medical needs.</strong></span></span></p>",
    "correct_choice_id": 13389,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 58788,
    "choices": [
      {
        "id": 234485,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol </span></span></span></span></p>"
      },
      {
        "id": 234486,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost </span></span></span></span></p>"
      },
      {
        "id": 234487,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brimonidine </span></span></span></span></p>"
      },
      {
        "id": 234488,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dorzolamide</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old female with a history of glaucoma presents to the ophthalmologist with complaints of blurred vision and eye irritation. The patient reports that she has been using an anti-glaucoma medication for the past six months, and her symptoms began to appear gradually over the past few weeks. Appearance of eye is as shown in the figure. Which of the following anti-glaucoma drugs is likely to produce this adverse effect?</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/26/screenshot-2024-09-26-160127.png\" style=\"height:154px; width:300px\" /></span></span></span></span></p>",
    "unique_key": "Q9687324",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672826,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Latanoprost. </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s symptoms and the image shows the clinical diagnosis of heterochromia iridis. It is a well-known adverse effect of latanoprost, which is a prostaglandin analog used in the treatment of glaucoma. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost can cause: </span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pigmentation of Iris: It is also known as heterochromia iridis</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Growth of Eyelashes: It is also called hypertrichosis</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Macular Edema</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Worsening of inflammation: So contraindicated in patients with uveitis.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>",
    "correct_choice_id": 234486,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3289,
    "choices": [
      {
        "id": 13135,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycopyrrolate</span></span></span></p>"
      },
      {
        "id": 13136,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></span></span></p>"
      },
      {
        "id": 13137,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neostigmine</span></span></span></p>"
      },
      {
        "id": 13138,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fentanyl</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which one of the following drugs increases gastrointestinal motility?</span></span></span></p>",
    "unique_key": "Q5455340",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672849,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Neostigmine </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Neostigmine increases gastrointestinal motility </strong>by inhibiting <strong>acetylcholinesterase</strong>, the enzyme responsible for <strong>breaking down</strong> <strong>acetylcholine at cholinergic synapses</strong>. This action results in an <strong>increased concentration of acetylcholine</strong> at the neuromuscular junctions within the <strong>gastrointestinal tract,</strong> enhancing<strong> smooth muscle contraction </strong>and thereby <strong>promoting gastrointestinal motility.</strong> <strong>Neostigmine&#39;s </strong>effect on the <strong>gastrointestinal system</strong> is part of its broader pharmacological profile as a<strong> parasympathomimetic agent,</strong> which<strong> stimulates the parasympathetic nervous system</strong> and can be used to treat conditions such as <strong>postoperative abdomina</strong>l <strong>distension and urinary retention.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycopyrrolate:</strong> Glycopyrrolate is an <strong>anticholinergic drug </strong>that <strong>decreases gastrointestinal motility.</strong> It works by blocking <strong>acetylcholine receptors </strong>in the<strong> gastrointestinal tract</strong>, <strong>reducing smooth muscle contractions and secretions</strong>. <strong>Glycopyrrolate </strong>is often used<strong> preoperatively to reduce salivary, tracheobronchial, and pharyngeal secretions</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atropine:</strong> Atropine is another <strong>anticholinergic drug </strong>that <strong>reduces gastrointestinal motility </strong>by inhibiting the action of <strong>acetylcholine on muscarinic receptors in the gut</strong>. This results in <strong>decreased muscle tone and motility</strong> in the <strong>digestive tract.</strong> Atropine is used in various clinical settings, including <strong>pre-anesthetic medication</strong> to <strong>reduce salivation and increase heart rate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fentanyl:</strong> Fentanyl is a<strong> synthetic opioid analgesic, </strong>which<strong> does not </strong>directly affect<strong> gastrointestinal motility </strong>as<strong> its primary action</strong>. However, <strong>opioids</strong>, in general, are known to <strong>reduce gastrointestinal motility </strong>due to their <strong>inhibitory effects </strong>on the <strong>enteric nervous system</strong>, leading to <strong>constipation </strong>as a common side effect.<strong> Fentanyl&#39;s main </strong>use is for <strong>pain management</strong>, <strong>not for modulating gastrointestinal motility</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Neostigmine</strong>, a <strong>parasympathomimetic agent</strong>, <strong>increases gastrointestinal motility</strong> by <strong>inhibiting acetylcholinesterase</strong> and <strong>increasing</strong> <strong>acetylcholine levels</strong>. In contrast, <strong>anticholinergic drugs like glycopyrrolate and atropine decrease gastrointestinal motility </strong>by blocking <strong>acetylcholine receptors.</strong> <strong>Fentanyl, an opioid analgesic, </strong>can<strong> indirectly decrease gastrointestinal motility </strong>as a side effect of its<strong> analgesic use. </strong></span></span></p>",
    "correct_choice_id": 13137,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3277,
    "choices": [
      {
        "id": 13087,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha agonist</span></span></span></p>"
      },
      {
        "id": 13088,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetazolamide</span></span></span></p>"
      },
      {
        "id": 13089,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blockers</span></span></span></p>"
      },
      {
        "id": 13090,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandin analogues</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient present with diabetic macular edema with glaucoma. Which of the following drug should be avoided in this patient?</span></span></span></p>",
    "unique_key": "Q4795762",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672842,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Prostaglandin analogues</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Prostaglandin analogues s</strong>hould be<strong> avoided in patients with diabetic macular edema </strong>because they can <strong>exacerbate</strong> the condition. These drugs, including <strong>Latanoprost and Bimatoprost, </strong>are known to <strong>potentially cause cystoid macular edema (CME)</strong>, which can <strong>worsen existing macular edema</strong> in<strong> diabetic patients. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Alpha agonists: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;These are<strong> not primarily </strong>associated with<strong> exacerbation of macular edema</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Acetazolamide</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: &nbsp;A<strong> carbonic anhydrase inhibitor, not </strong>typically associated with <strong>causing or worsening macular edema</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Beta blockers:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Commonly used in glaucoma</strong> to <strong>reduce intraocular pressure</strong> without affecting macular edema.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Prostaglandin analogues </strong>can <strong>worsen macular edema</strong> and therefore should be <strong>avoided in patients with diabetic macular edema. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Important<strong> adverse effects of anti-glaucoma drugs</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-115656.jpg\" style=\"height:720px; width:1000px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: KDT 8<sup>th</sup>/169</span></strong></span></span></p>",
    "correct_choice_id": 13090,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3312,
    "choices": [
      {
        "id": 13227,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Organophosphate poisoning</span></span></span></p>"
      },
      {
        "id": 13228,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dhatura poisoning</span></span></span></p>"
      },
      {
        "id": 13229,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Opioid poisoning</span></span></span></p>"
      },
      {
        "id": 13230,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pontine hemorrhage</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents to emergency with pinpoint pupil, salivation, lacrimation, tremors and red tears. Plasma cholinesterase level was 30% of normal. Most probable Diagnosis is? </span></span></span></p>",
    "unique_key": "Q2304902",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672858,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Organophosphate poisoning</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation of <strong>pinpoint pupils (miosis), excessive salivation, lacrimation, muscle tremors, </strong>and the unusual finding of <strong>red tears</strong>, combined with significantly <strong>reduced plasma cholinesterase levels (30% of normal), </strong>strongly suggests <strong>organophosphate poisoning. </strong>Organophosphates <strong>inhibit acetylcholinesterase, </strong>leading to the <strong>accumulation of acetylcholine at cholinergic synapses and neuromuscular junctions</strong>. This results in <strong>overstimulation of muscarinic and nicotinic receptors</strong>, manifesting as the <strong>muscarinic signs (miosis, salivation, lacrimation) and nicotinic signs (muscle tremors) </strong>observed.<strong> Organophosphates </strong>are commonly used in agriculture as <strong>pesticides</strong>, and <strong>exposure </strong>can occur through <strong>inhalation, ingestion, or skin contact</strong>, which is consistent with the patient being a<strong> farm worker</strong>. The <strong>red tears </strong>could be related to <strong>conjunctival </strong>exposure to the <strong>chemical or a secondary effect</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Dhatura poisoning:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dhatura</strong>, a <strong>plant </strong>containing <strong>anticholinergic tropane alkaloids </strong>(e.g., <strong>atropine, scopolamine</strong>), would cause <strong>anticholinergic syndrome</strong>, characterized by <strong>dry skin and mucous membranes, flushed face, hyperthermia, mydriasis (dilated pupils), and hallucinations. </strong>This is<strong> opposite to the cholinergic signs </strong>seen in the patient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Opioid poisoning:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Opioid poisoning can cause <strong>pinpoint pupils</strong>, but the predominant symptoms would also include <strong>respiratory depression and decreased level of consciousness</strong>, which are not mentioned in the scenario. <strong>Opioids do not </strong>cause <strong>excessive salivation or lacrimation</strong>, nor do they affect <strong>plasma cholinesterase levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pontine hemorrhage:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While pontine hemorrhage can lead to<strong> pinpoint pupils </strong>due to disruption of the <strong>sympathetic pathways</strong>, it would also typically present with <strong>acute neurological deficits like altered consciousness, paralysis, or other focal neurological signs</strong>, which are not described in this scenario. Additionally,<strong> pontine hemorrhage </strong>would <strong>not explain </strong>the <strong>reduced plasma cholinesterase levels </strong>or the specific combination of symptoms mentioned.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective is to recognize the <strong>clinical presentation of organophosphate poisoning,</strong> which includes signs of <strong>cholinergic</strong> excess such as <strong>miosis, excessive salivation, lacrimation, and muscle tremors,</strong> along with <strong>reduced plasma cholinesterase levels</strong>. <strong>Understanding the clinical features and laboratory findings </strong>associated with this condition is critical for<strong> prompt diagnosis and treatment</strong>.</span></span></span></p>",
    "correct_choice_id": 13227,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3282,
    "choices": [
      {
        "id": 13107,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline</span></span></span></p>"
      },
      {
        "id": 13108,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Noradrenaline</span></span></span></p>"
      },
      {
        "id": 13109,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoprenaline</span></span></span></p>"
      },
      {
        "id": 13110,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dobutamine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following acts on &alpha;1, &alpha;2 and &beta;1 receptors but does not stimulate &beta;2 receptors?</span></span></span></p>",
    "unique_key": "Q7687229",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672846,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Noradrenaline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Noradrenaline (norepinephrine) acts on &alpha;1, &alpha;2, and &beta;1 adrenergic receptors.</strong> It is a naturally occurring <strong>catecholamine </strong>that functions as a<strong> neurotransmitter and hormone in the body</strong>. Noradrenaline&#39;s action on <strong>&alpha;1 and &alpha;2 receptors</strong> is responsible for its <strong>vasoconstrictive effects</strong>, while its action on <strong>&beta;1 receptors</strong> affects <strong>cardiac output by increasing the heart rate </strong>and <strong>myocardial</strong> <strong>contractility.</strong> It <strong>does not stimulate &beta;2 receptors</strong>, which are primarily involved in <strong>bronchodilation and vasodilation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-115834.jpg\" style=\"height:338px; width:1000px\" /></span></u></strong></span></span></p>",
    "correct_choice_id": 13108,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3351,
    "choices": [
      {
        "id": 13383,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost </span></span></p>"
      },
      {
        "id": 13384,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol</span></span></p>"
      },
      {
        "id": 13385,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dorzolamide </span></span></p>"
      },
      {
        "id": 13386,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pilocarpine</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-glaucoma drug that acts by increasing uveoscleral outflow is:</span></span></span></p>",
    "unique_key": "Q1003133",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672817,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Latanoprost</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Latanoprost</strong> is an <strong>anti-glaucoma medication</strong> that works by <strong>increasing the uveoscleral outflow of aqueous humor, </strong>which helps to <strong>lower intraocular pressure </strong>in patients with<strong> glaucoma or ocular hypertension.</strong> It is a <strong>prostaglandin analog,</strong> which <strong>distinguishes its</strong> <strong>mechanism of action</strong> from other classes of <strong>glaucoma medications.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Timolol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Timolol is a<strong> beta-blocke</strong>r used in the <strong>treatment of glaucoma,</strong> but it works by <strong>decreasing aqueous</strong> <strong>humor production in the eye,</strong> not by increasing uveoscleral outflow.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Dorzolamide:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Dorzolamide is a carbonic anhydrase inhibitor</strong> that also<strong> reduces intraocular pressure</strong> by <strong>decreasing aqueous humor production</strong>. It does not act by increasing uveoscleral outflow.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pilocarpine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Pilocarpine is a muscarinic agonist</strong> that reduces i<strong>ntraocular pressure by increasing the outflow of</strong> <strong>aqueous humor</strong> through the <strong>trabecular meshwork,</strong> which is different from increasing uveoscleral outflow.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to recognize the<strong> mechanism of action </strong>of different <strong>anti-glaucoma medications</strong>, particularly identifying <strong>latanoprost as</strong> a drug that<strong> reduces intraocular pressure </strong>by <strong>increasing uveoscleral outflow. </strong>Understanding how various <strong>anti-glaucoma </strong>drugs work is essential for selecting appropriate treatment options based on the individual needs and pathophysiology of the patient&#39;s glaucoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism of action of anti-glaucoma drugs</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/99.jpg\" style=\"height:359px; width:1000px\" /></span></span></strong></p>",
    "correct_choice_id": 13383,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3306,
    "choices": [
      {
        "id": 13203,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline 0.5 ml of 1:1000 solution by intramuscular route</span></span></p>"
      },
      {
        "id": 13204,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenaline 1 ml of 1:10000 by intravenous route</span></span></p>"
      },
      {
        "id": 13205,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine 3 mg intravenously</span></span></p>"
      },
      {
        "id": 13206,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenosine 12 mg intravenously</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment of choice for anaphylactic shock is</span></span></p>",
    "unique_key": "Q8792050",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672855,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Adrenaline 0.5 ml of 1:1000 solution by intramuscular route</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Adrenaline</strong> is the treatment of choice for <strong>anaphylactic shock</strong> due to its <strong>rapid onset of action </strong>and its effects on<strong> both alpha and beta-adrenergic receptors</strong>. It reverses the symptoms of <strong>anaphylaxis by causing peripheral vasoconstriction, bronchodilation, increasing cardiac output</strong>, and<strong> preventing </strong>further release of <strong>mediators </strong>from <strong>mast cells and basophils</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Adrenaline 1 ml of 1</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>:10000 by intravenous route:</strong>&nbsp;This is<strong> less </strong>preferred initially due to the <strong>risk of adverse effects </strong>with <strong>intravenous administration</strong> unless <strong>absolutely necessary and under close monitoring. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Atropine 3 mg intravenously:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong> Not used in anaphylaxis</strong>, as it does not address the pathophysiological changes involved in anaphylactic shock. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Adenosine 12 mg intravenously:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Not indicated for anaphylaxis </strong>as it&#39;s primarily<strong> used for </strong>certain types of <strong>supraventricular tachycardias.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For<strong> anaphylactic shock</strong>, <strong>adrenaline </strong>is administered <strong>intramuscularly in a 1:1000 concentration as the first-line treatment</strong>. This route is preferred over <strong>subcutaneous or intravenous administration </strong>due to its<strong> effectiveness and safety profile</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harrison 19<sup>th</sup>/2117</span></span></strong></p>",
    "correct_choice_id": 13203,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3325,
    "choices": [
      {
        "id": 13279,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pirenzepine </span></span></span></p>"
      },
      {
        "id": 13280,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tolterodine</span></span></span></p>"
      },
      {
        "id": 13281,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropicamide </span></span></span></p>"
      },
      {
        "id": 13282,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"margin-left:6px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is an antimuscarinic drug useful in overactive bladder?</span></span></span></p>",
    "unique_key": "Q3853219",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672862,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp; B) Tolterodine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Overactive bladder (Detrusor instability)</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Detrusor instability or overactive bladder </strong>is characterized by <strong>uninhibited, unstable contractions of the detrusor muscle.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Since <strong>detrusor contracts</strong> under <strong>parasympathetic influence</strong>, <strong>anticholinergic drugs</strong> are used to <strong>treat overactive bladder.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;These agents<strong> lower intravesical pressure</strong>,<strong> increase capacity </strong>and<strong> reduce the frequency of contractions</strong> by <strong>antagonizing</strong> <strong>parasympathetic tone of bladder.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;These agents include: -</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">S: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">olefenacin</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">O: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; O</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">xybutynin </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">F: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; F</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">lavoxate</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; T</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">olterodine and <strong>T</strong>rospium</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">bla<strong>DAR:</strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<strong>DAR</strong>ifenacin</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A. Pirenzepine:</strong> Pirenzepine is primarily used as a<strong> selective M1 muscarinic receptor antagonist</strong> in the treatment of <strong>peptic</strong> <strong>ulcers.</strong> It is <strong>not indicated </strong>for the treatment of<strong> overactive bladder.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Tropicamide:</strong> Tropicamide is a<strong> muscarinic receptor antagonist </strong>used as a <strong>mydriatic agent</strong> to induce <strong>pupillary dilation</strong> for <strong>ophthalmic examinations. </strong>It is <strong>not indicated</strong> for the treatment of <strong>overactive bladder.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atropine:</strong> Atropine is a <strong>non-selective muscarinic receptor antagonist</strong> used for various purposes, including the <strong>treatment of bradycardia, organophosphate poisoning, </strong>and as a<strong> preanesthetic medication</strong>. While it can <strong>reduce detrusor muscle activity</strong>, it is <strong>not </strong>commonly used for the<strong> treatment of overactive bladder</strong> due to its<strong> non-selective nature and potential side effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tolterodine,</strong> as an <strong>antimuscarinic agent, </strong>is commonly used in the <strong>treatment of overactive bladder</strong> due to its <strong>ability to reduce urinary frequency, urgency, and urge incontinence </strong>by <strong>blocking muscarinic receptors</strong> in the<strong> bladder. </strong></span></span></p>",
    "correct_choice_id": 13280,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3626,
    "choices": [
      {
        "id": 14483,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyrotoxicosis</span></span></span></p>"
      },
      {
        "id": 14484,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Variant angina</span></span></span></p>"
      },
      {
        "id": 14485,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Migraine</span></span></span></p>"
      },
      {
        "id": 14486,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertension</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol can be used in all of the following conditions except.</span></span></span></p>",
    "unique_key": "Q7024934",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672828,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Variant angina&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol</strong> is <strong>contraindicated in variant angina (Prinzmetal&#39;s angina) </strong>because it is a<strong> non-selective beta-blocke</strong>r that can <strong>exacerbate</strong> <strong>symptoms. Variant angina </strong>is caused by <strong>coronary artery spasms,</strong> and<strong> beta-blockers </strong>like <strong>propranolol </strong>can<strong> increase the risk</strong> of these <strong>spasms</strong> by leaving <strong>unopposed alpha-mediated vasoconstriction</strong>, potentially worsening the condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Thyrotoxicosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Propranolol</strong> is used in <strong>thyrotoxicosis</strong> to provide <strong>symptomatic relief</strong> from<strong> hyperthyroid symptoms </strong>such as <strong>tachycardia, anxiety, and tremors</strong>. It can also <strong>inhibit peripheral conversion of T4 to T3.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Migraine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Propranolol</strong> is used as a<strong> prophylactic treatment for migraine</strong>. It helps <strong>reduce the frequency </strong>and <strong>severity of</strong> <strong>migraine attacks.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hypertension:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Propranolol </strong>can be used in the management of <strong>hypertension</strong>. It <strong>lowers blood pressure</strong> by <strong>reducing cardiac</strong> <strong>output</strong> and <strong>inhibiting</strong> <strong>renin</strong> release from the<strong> kidneys.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational goal is to understand the <strong>therapeutic uses </strong>and <strong>contraindications of propranolol,</strong> a <strong>non-selective beta-blocke</strong>r. Recognizing that <strong>propranolol is contraindicated in variant angina </strong>due to its <strong>potential to worsen coronary artery spasms </strong>highlights the importance of considering the specific clinical context when selecting beta-blockers for treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indications of &beta;-Blockers:</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/88.jpg\" style=\"height:439px; width:1000px\" /></span></span></strong></p>",
    "correct_choice_id": 14484,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3302,
    "choices": [
      {
        "id": 13187,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchodilation by beta-2 receptors</span></span></span></p>"
      },
      {
        "id": 13188,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiovascular effects of beta-1 receptors</span></span></span></p>"
      },
      {
        "id": 13189,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Action on blood vessels by alpha-1 receptors</span></span></span></p>"
      },
      {
        "id": 13190,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Action on presynaptic alpha-2 receptors</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the management of anaphylactic shock, which of the following action of adrenaline is not required? </span></span></p>",
    "unique_key": "Q5649357",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672853,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Action on presynaptic alpha-2 receptors</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Adrenaline (epinephrine)</strong> is the drug of choice for the treatment of <strong>anaphylactic shock</strong>, primarily due to its effects on<strong> alpha-1, beta-1, and beta-2 adrenergic receptors. </strong>These actions include:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha-1 receptor</strong> stimulation, which causes <strong>vasoconstriction,</strong> critical for <strong>increasing blood pressure</strong> during the <strong>hypotensive </strong>state of <strong>anaphylactic shock.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-1 receptor</strong> stimulation, which leads to <strong>increased cardiac output</strong>, providing necessary<strong> cardiovascular support.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-2 receptor</strong> stimulation, essential for <strong>reversing bronchoconstriction</strong> and easing breathing in patients experiencing <strong>anaphylaxis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The action on <strong>presynaptic alpha-2 receptors</strong> is <strong>not</strong> beneficial in <strong>anaphylactic shock.</strong> <strong>Alpha-2 receptors </strong>typically function to inhibit the release of <strong>norepinephrine (noradrenaline), </strong>acting as a<strong> negative feedback mechanism</strong>. In the setting of anaphylactic shock, <strong>inhibition of neurotransmitter </strong>release is<strong> counterproductive</strong>, as<strong> maximal sympathetic stimulation</strong> is required to counter the effects of <strong>anaphylaxis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Bronchodilation</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> by<strong> beta-2 receptors </strong>is vital for reversing <strong>airway constriction </strong>in <strong>anaphylaxis</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cardiovascular</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> effects of<strong> beta-1 receptors </strong>are crucial for supporting <strong>heart function during shock</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Vasoconstriction</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> by<strong> alpha-1 receptors </strong>is necessary to<strong> counteract </strong>the profound <strong>vasodilation and hypotension</strong> seen in <strong>anaphylactic shock.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>presynaptic alpha-2 receptor</strong> action of <strong>adrenaline,</strong> which would normally <strong>inhibit norepinephrine</strong> release and <strong>dampen</strong> <strong>sympathetic responses</strong>, is <strong>not </strong>desired in the treatment of <strong>anaphylactic shock</strong>, where a <strong>strong sympathetic </strong>response is needed to combat severe <strong>allergic reactions.</strong></span></span></span></p>",
    "correct_choice_id": 13190,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3313,
    "choices": [
      {
        "id": 13231,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamsulosin</span></span></span></p>"
      },
      {
        "id": 13232,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Finasteride</span></span></span></p>"
      },
      {
        "id": 13233,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prazosin</span></span></span></p>"
      },
      {
        "id": 13234,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Testosterone</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man came with urinary symptoms of increased frequency and hesitation. The patient was diagnosed with benign hyperplasia of prostate. Which of the drugs will help to prevent further growth and possibly reduces the size of the prostate? </span></span></span></p>",
    "unique_key": "Q1397598",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672859,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Finasteride</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Finasteride is a <strong>5-alpha reductase inhibitor </strong>that reduces the conversion of <strong>testosterone to dihydrotestosterone (DHT)</strong>, which is a <strong>more potent androgen</strong> in the <strong>prostate gland</strong>. By<strong> lowering the levels of DHT, </strong>finasteride can prevent further <strong>growth of the prostate</strong> and potentially <strong>reduce its size.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Tamsulosin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; This medication is an <strong>alpha-1A antagonist</strong> that <strong>relaxes the muscles </strong>in the<strong> prostate and bladder neck,</strong> <strong>improving urine flow,</strong> but<strong> does not</strong> affect<strong> prostate size. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Prazosin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; While this <strong>non-selective alpha-1 antagonist</strong> can improve symptoms of<strong> benign prostatic hyperplasia (BPH</strong>) by <strong>relaxing prostate and bladder neck muscles, </strong>it <strong>doesn&#39;t reduce prostate size </strong>and is noted for <strong>causing postural hypotension. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Testosterone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Administration of testosterone can actually <strong>exacerbate BPH</strong> due to its <strong>conversion to DHT </strong>within the <strong>prostate, </strong>leading to<strong> further growth.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a patient diagnosed with <strong>BPH, finasteride </strong>is the <strong>drug of choice</strong> to not only <strong>alleviate urinary symptoms</strong> but also potentially <strong>reduce prostate size</strong> due to its mechanism of<strong> inhibiting the enzyme 5-alpha reductase</strong> and <strong>lowering intraprostatic DHT levels.</strong></span></span></span></p>",
    "correct_choice_id": 13232,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3291,
    "choices": [
      {
        "id": 13143,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doxazosin</span></span></span></p>"
      },
      {
        "id": 13144,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phentolamine</span></span></span></p>"
      },
      {
        "id": 13145,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamsulosin</span></span></span></p>"
      },
      {
        "id": 13146,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terazosin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following alpha-blocker drugs is used in the treatment of benign hypertrophy of the prostate without producing significant hypotension?</span></span></span></p>",
    "unique_key": "Q5843975",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672851,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Tamsulosin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tamsulosin </strong>is <strong>an alpha-1 receptor blocker </strong>with <strong>selectivity for the alpha-1A receptors</strong>, which are primarily located in the <strong>prostate</strong> <strong>and bladder neck.</strong> This <strong>selectivity </strong>allows <strong>tamsulosin to relax the smooth muscle </strong>in these areas, <strong>improving urinary flow </strong>and symptoms associated with <strong>benign prostatic hypertrophy (BPH) </strong>without significantly affecting <strong>vascular smooth muscle tone </strong>and thus <strong>minimizing </strong>the risk of <strong>hypotension</strong>. This characteristic makes<strong> tamsulosin </strong>particularly <strong>suitable </strong>for the treatment of<strong> BPH</strong>, providing <strong>symptomatic relief </strong>with a <strong>lower risk of cardiovascular side effects </strong>compared to <strong>non-selective alpha-blockers.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Doxazosin:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doxazosin is a<strong> non-selective alpha-1 antagonist. </strong>It is used to treat <strong>hypertension and BPH</strong>, but it <strong>does not </strong>have the same degree of selectivity for the<strong> alpha-1A receptors as tamsulosin </strong>and can cause more<strong> pronounced hypotension </strong>as a side effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Phentolamine:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phentolamine is a<strong> non-selective alpha-adrenergic antagonist</strong>, blocking both<strong> alpha-1 and alpha-2 receptors. </strong>It is primarily used in the management of<strong> hypertensive emergencies </strong>related to<strong> pheochromocytoma </strong>and is<strong> not </strong>commonly used in the treatment of <strong>BPH</strong>. Due to its <strong>non-selectivity, </strong>it can cause significant <strong>hypotension.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Terazosin:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Terazosin is another<strong> non-selective alpha-1 antagonist </strong>used to treat <strong>hypertension and symptoms of BPH</strong>. While it is effective in <strong>relieving urinary symptoms </strong>related to <strong>BPH,</strong> its<strong> non-selective</strong> action on<strong> alpha-1 receptors </strong>can also lead to more <strong>pronounced hypotension </strong>compared to <strong>tamsulosin.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><strong><u> </u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tamsulosin,</strong> with its selectivity for <strong>alpha-1A receptors,</strong> is preferable for treating <strong>BPH symptoms</strong> as it <strong>minimizes </strong>the risk of <strong>hypotension</strong>. In contrast, <strong>non-selective alpha-blockers </strong>like<strong> doxazosin, terazosin, and phentolamine </strong>can be used in <strong>BPH </strong>but may have a<strong> higher risk </strong>of causing <strong>hypotension</strong>. </span></span></span></p>",
    "correct_choice_id": 13145,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3273,
    "choices": [
      {
        "id": 13071,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachyphylaxis</span></span></span></p>"
      },
      {
        "id": 13072,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nicotinic actions of acetylcholine</span></span></span></p>"
      },
      {
        "id": 13073,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biphasic response of adrenaline</span></span></span></p>"
      },
      {
        "id": 13074,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vasomotor reversal of Dale</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Repeated administration of a drug produces the following effect on blood pressure (as shown in the diagram). What is this phenomenon known as?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture1.jpg\" style=\"height:160px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q2060792",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672840,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Tachyphylaxis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image shows a <strong>blood pressure tracing of a dog</strong>, with repeated administrations of a <strong>drug indicated by &#39;T&#39; (for Tyramine 0.3 mg/kg). </strong>The tracing shows<strong> successive spikes in blood pressure </strong>following each <strong>administration of the drug</strong>, with the<strong> magnitude of the spikes appearing to diminish over time</strong>. This <strong>phenomenon </strong>is known as <strong>tachyphylaxis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tachyphylaxis </strong>refers to a <strong>rapidly decreasing response </strong>to a drug following its <strong>initial administration</strong>. In the context of the <strong>blood pressure tracing </strong>provided, it appears that the<strong> initial doses of Tyramine </strong>produce significant <strong>increases in blood pressure</strong>, but as <strong>more doses are administered, </strong>the effect becomes <strong>less pronounced. </strong>This is a classic characteristic of<strong> tachyphylaxis, </strong>where the <strong>body&#39;s response to a drug diminishes </strong>with <strong>repeated dosing over a short period.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Nicotinic actions of acetylcholine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is<strong> not </strong>the <strong>correct answer</strong>. The<strong> nicotinic actions</strong> of <strong>acetylcholine </strong>refer to the effect acetylcholine has on<strong> nicotinic acetylcholine</strong> <strong>receptors,</strong> which are<strong> ligand-gated ion channels</strong> found in the <strong>nervous system and at the neuromuscular junction</strong>. Normally <strong>acetylcholine decreases blood pressure and heart rate </strong>due to its action of <strong>muscarinic receptors. </strong>However, if we give <strong>very high dose of acetylcholine </strong>after giving <strong>atropine (to block muscarinic receptors), </strong>then it shows <strong>increase in BP and heart rate</strong>. This is due to the action of <strong>acetylcholine on nicotinic receptors</strong> present on <strong>ganglia</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Biphasic response of adrenaline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option is<strong> incorrect. </strong>A <strong>biphasic response </strong>to<strong> adrenaline </strong>would involve an <strong>initial phase </strong>in which there is <strong>increase in blood pressure (due to stimulation of alpha 1 receptors) </strong>followed by a <strong>second phase </strong>in which there is fall in <strong>blood pressure (due to action on beta 2 receptors). </strong>The <strong>tracing does not </strong>show a <strong>biphasic response; </strong>it shows a <strong>series of responses </strong>that <strong>diminish over time, consistent </strong>with <strong>tachyphylaxis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Vasomotor reversal of Dale</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Vasomotor reversal of Dale </strong>is a phenomenon where <strong>adrenaline </strong>can produce a <strong>paradoxical decrease in blood pressure </strong>due to <strong>stimulation of vasodilatory beta-adrenergic receptors</strong>, especially after <strong>pre-treatment with drugs </strong>that <strong>block alpha-adrenergic receptors. </strong>This is <strong>not </strong>what is depicted in the tracing.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on the image, the correct answer is:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachyphylaxis is&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">a <strong>diminishing response </strong>to <strong>repeated administrations </strong>of the same dose of a drug over a short period. This is a common pharmacological phenomenon often seen with drugs that<strong> act on receptors or other cellular targets </strong>that can become <strong>desensitized or down-regulated with frequent stimulation</strong>.</span></span></p>",
    "correct_choice_id": 13071,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3911,
    "choices": [
      {
        "id": 15623,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Furosemide</span></span></span></span></span></span></p>"
      },
      {
        "id": 15624,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Pyrazinamide</span></span></span></span></span></span></p>"
      },
      {
        "id": 15625,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Thiazides</span></span></span></span></span></span></p>"
      },
      {
        "id": 15626,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Sulfinpyrazone</span></span></span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Gout is precipitated by all except?</span></span></span></span></span></p>",
    "unique_key": "Q1822200",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672839,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. D) Sulfinpyrazone</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D:</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Sulfinpyrazone </strong>is a <strong>medication used to treat gout</strong>, as it helps to <strong>reduce high levels of uric acid. </strong>It is a <strong>uricosuric agent </strong>that <strong>increases </strong>the <strong>excretion of uric acid in the urine</strong>, thereby <strong>lowering the uric acid levels </strong>in the <strong>blood </strong>and helping to <strong>prevent gout attacks</strong>. Therefore, it does not precipitate gout but is used to manage it.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Furosemide:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This is a <strong>loop diuretic </strong>that can <strong>lead to increased uric acid levels </strong>in the <strong>blood by competing with uric acid </strong>for excretion in the renal tubules, which can precipitate gout.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Pyrazinamide:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This <strong>antitubercular medication </strong>can cause <strong>hyperuricemia </strong>by <strong>reducing renal excretion of uric acid</strong>, which can precipitate gout.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Thiazides:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">These <strong>diuretics </strong>can also <strong>increase uric acid levels </strong>by similar <strong>mechanisms to furosemide</strong>, which can lead to gout flare-ups.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The educational goal is to <strong>recognize the medications</strong> that can <strong>precipitate gout by increasing uric acid levels</strong> and to <strong>differentiate</strong> them from those that are <strong>used to treat gout.</strong></span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Drugs that cause Hyperuricemia</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Alcohol</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Thiazides</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Loop diuretics (Furosemide, Torsemide etc.)</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Salicylates</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Pyrazinamide</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ethambutol</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Nicotinic acid</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Cyclosporine</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytotoxic anticancer drugs</span></span></li>\r\n</ul>",
    "correct_choice_id": 15626,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3309,
    "choices": [
      {
        "id": 13215,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agonist at &alpha;1 and &beta;1</span></span></span></p>"
      },
      {
        "id": 13216,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agonist at &alpha;1 and &beta;2</span></span></span></p>"
      },
      {
        "id": 13217,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agonist at &beta;1 and &beta;2</span></span></span></p>"
      },
      {
        "id": 13218,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agonist at &beta;1 and antagonist at &alpha;1</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Testing of a drug related to autonomic nervous system was planned. The drug and a placebo were administered in a healthy volunteer? The following effect were seen. What are the likely characteristics of the drug?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-121656.jpg\" style=\"height:516px; width:1000px\" /></span></span></span></p>",
    "unique_key": "Q3596102",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672857,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Agonist at &beta;1 and &beta;2</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> drug shows </strong>characteristics of<strong> increased heart rate (tachycardia) and increased systolic blood pressure</strong>, which are indicative of <strong>&beta;1 agonist action.</strong> The <strong>decrease in diastolic blood pressure </strong>and the<strong> presence of tremors suggest &beta;2 agonist </strong>activity, as <strong>&beta;2 receptors</strong> are responsible for <strong>vasodilation in certain blood vessels </strong>and can cause<strong> tremors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. &nbsp;Agonist at &alpha;1 and &beta;1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; <strong>Incorrect </strong>because <strong>&alpha;1 stimulation </strong>would <strong>increase both systolic and diastolic blood pressure,</strong> which is not observed. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Agonist at &alpha;1 and &beta;2:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; <strong>Incorrec</strong>t because <strong>&alpha;1 agonist action</strong> would<strong> not</strong> result in<strong> decreased diastolic blood pressure. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. &nbsp;Agonist at &beta;1 and antagonist at &alpha;1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong> Incorrect</strong> because an <strong>&alpha;1 antagonist</strong> would lead to a<strong> decrease in both systolic and diastolic blood pressure, not an increase in systolic pressure.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The characteristic effects of<strong> tachycardia and changes in blood pressure,</strong> along with the <strong>presence of tremors</strong>, suggest that the drug has <strong>agonistic activity at &beta;1 and &beta;2 receptors,</strong> making it a likely candidate for a <strong>beta-adrenergic agonist</strong> with <strong>both cardiac and</strong> <strong>peripheral actions.</strong></span></span></p>",
    "correct_choice_id": 13217,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3915,
    "choices": [
      {
        "id": 15639,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fexofenadine </span></span></span></p>"
      },
      {
        "id": 15640,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cetirizine</span></span></p>"
      },
      {
        "id": 15641,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loratadine </span></span></p>"
      },
      {
        "id": 15642,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Promethazine</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A person is planning a road trip from Chandigarh to Manali. He developed severe vomiting during his last trip to Manali. Which of the following drug should be taken by the person to avoid the motion sickness? </span></span></p>",
    "unique_key": "Q2931484",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672841,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Promethazine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D:</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Promethazine</strong> is recommended for this individual because it is a <strong>first-generation antihistamine </strong>with <strong>anti-cholinergic properties</strong> that are <strong>effective in preventing </strong>and <strong>treating motion sickness. </strong>While the <strong>drug of choice </strong>(DOC) for prophylaxis of motion sickness is <strong>scopolamine,</strong> <strong>promethazine </strong>is a suitable alternative due to its <strong>anti-cholinergic activity </strong>which can help <strong>counteract the vestibular disturbances</strong> that <strong>lead to motion sickness.</strong></span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Fexofenadine: </span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;A <strong>second-generation antihistamine</strong> primarily <strong>used for allergies,</strong> not effective for motion sickness due to lack of anti-cholinergic properties. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Cetirizine: </span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;Similar to Fexofenadine, it is a <strong>second-generation antihistamine</strong> that is not used for motion sickness. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Loratadine: </span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;Also a <strong>second-generation antihistamine</strong> with <strong>little to no anti-cholinergic activity,</strong> and thus not recommended for motion sickness.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong><u> </u></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>First-generation antihistamines,</strong> like <strong>Promethazine,</strong> can <strong>cross the blood-brain barrier</strong> and cause <strong>sedation,</strong> have <strong>anti-cholinergic side</strong> <strong>effects</strong>, and are useful in <strong>treating </strong>various conditions including <strong>allergies, motion sickness, drug-induced parkinsonism, muscular dystonias,</strong> and the <strong>common cold. </strong>In contrast, <strong>second-generation antihistamines, </strong>such as <strong>Fexofenadine, Cetirizine, </strong>and <strong>Loratadine,</strong> do <strong>not cross the blood-brain barrier,</strong> generally do <strong>not cause sedation</strong>, do <strong>not have anti-cholinergic activity</strong>, and are primarily useful for allergies.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-154406.jpg\" style=\"height:394px; width:1000px\" /></span></span></p>",
    "correct_choice_id": 15642,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3287,
    "choices": [
      {
        "id": 13127,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine</span></span></span></p>"
      },
      {
        "id": 13128,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dimercaprol</span></span></span></p>"
      },
      {
        "id": 13129,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physostigmine</span></span></span></p>"
      },
      {
        "id": 13130,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pralidoxime</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old farm worker is rushed to a nearby emergency department after an accidental exposure to parathion. Which of the following drugs can be given to increase the activity of his acetyl cholinesterase?</span></span></span></p>",
    "unique_key": "Q7314033",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672848,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Pralidoxime</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pralidoxime</strong> is a drug used in the treatment of <strong>organophosphate poisoning,</strong> such as that caused by exposure to <strong>parathion.</strong> <strong>Organophosphates</strong> inhibit <strong>acetylcholinesterase</strong>, leading to an <strong>accumulation of acetylcholine</strong> at<strong> synapses and neuromuscular</strong> <strong>junctions,</strong> which results in <strong>cholinergic crisis </strong>symptoms. <strong>Pralidoxime</strong> works by<strong> reactivating acetylcholinesterase </strong>that has been <strong>inhibited by organophosphates</strong>, thereby <strong>restoring its activity and alleviating the symptoms of poisoning</strong>. It is <strong>most effective</strong> when <strong>administered as soon as possible after exposure.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A.</strong> <strong>Atropine:</strong> <strong>Atropine</strong> is <strong>drug of choice </strong>as an <strong>antidote in organophosphate poisoning</strong>, but it <strong>does not increase</strong> the activity of <strong>acetylcholinesterase. </strong>Instead, it<strong> serves to counteract the effects </strong>of excess<strong> acetylcholine on muscarinic receptors</strong>, thereby relieving symptoms such as<strong> bradycardia, salivation, and bronchoconstriction. Atropine does not </strong>affect the <strong>nicotinic receptor-mediated</strong> <strong>effects (e.g., muscle weakness, paralysis).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dimercaprol:</strong> Dimercaprol is a chelating <strong>agent </strong>used in the treatment of <strong>poisoning by heavy metals</strong>, such as <strong>arsenic, lead, and mercury</strong>. It is <strong>not </strong>used in the treatment of <strong>organophosphate poisoning </strong>and <strong>does not </strong>i<strong>ncrease acetylcholinesterase activity</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Physostigmine:</strong> Physostigmine is a <strong>cholinesterase inhibitor, </strong>and<strong> unlike pralidoxime, </strong>it would exacerbate the effects of <strong>organophosphate poisoning</strong> by further<strong> inhibiting acetylcholinesterase. </strong>Therefore, it is <strong>not used</strong> in the treatment of <strong>organophosphate poisoning </strong>and is <strong>contraindicated in such cases.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pralidoxime</strong> is used to<strong> reactivate acetylcholinesterase</strong> inhibited by organophosphates, thereby r<strong>educing the toxic accumulation of</strong> <strong>acetylcholine</strong>. This treatment, often used in <strong>conjunction with atropine to manage muscarinic symptoms,</strong> is critical in the management of <strong>organophosphate poisoning,</strong> highlighting the importance of <strong>specific antidotes in toxicological emergencies.</strong></span></span></span></p>",
    "correct_choice_id": 13130,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3333,
    "choices": [
      {
        "id": 13311,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angina</span></span></span></p>"
      },
      {
        "id": 13312,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial atrioventricular block</span></span></span></p>"
      },
      {
        "id": 13313,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiopathic hypertrophic subaortic cardiomyopathy</span></span></span></p>"
      },
      {
        "id": 13314,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial tremor</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol is useful in the treatment of all of the following EXCEPT? </span></span></span></p>",
    "unique_key": "Q2019229",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672814,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Partial atrioventricular block</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol </strong>is a <strong>non-selective beta blocker</strong>, which means it can <strong>block beta-1 and beta-2 adrenergic receptors.</strong> It is used in various <strong>cardiovascular and non-cardiovascular</strong> conditions due to <strong>its ability to slow heart rate,</strong> <strong>decrease myocardial oxygen demand, </strong>and <strong>reduce tremors. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol</strong> is <strong>contraindicated </strong>in patients with<strong> partial atrioventricular block </strong>as it can exacerbate the condition leading to <strong>complete heart block</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Angina:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Propranolol </strong>is used in the management of<strong> angina pectoris</strong> due to its <strong>ability to reduce myocardial oxygen demand</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Idiopathic:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>hypertrophic subaortic cardiomyopathy (HOCM):</strong> Beta blockers like <strong>propranolol </strong>are used in<strong> HOCM to reduce</strong> the <strong>outflow obstruction </strong>and <strong>improve symptoms. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Familial tremor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Propranolol</strong> is effective in<strong> reducing tremors </strong>in conditions like<strong> familial or essential tremor.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propranolol </strong>is <strong>contraindicated</strong> in patients with<strong> partial atrioventricular block </strong>as it can <strong>exacerbate the condition </strong>leading to <strong>complete</strong> <strong>heart block.</strong> It is, however, <strong>beneficial</strong> in conditions such as<strong> angina, HOCM, and familial tremors</strong>. Patients with <strong>variant angina</strong> <strong>(Prinzmetal&#39;s angina)</strong> <strong>should not&nbsp;</strong>&nbsp;be treated with <strong>propranolol due to the risk of coronary vasospasm.</strong></span></span></p>",
    "correct_choice_id": 13312,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3301,
    "choices": [
      {
        "id": 13183,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dobutamine</span></span></span></p>"
      },
      {
        "id": 13184,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopexamine</span></span></span></p>"
      },
      {
        "id": 13185,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine</span></span></span></p>"
      },
      {
        "id": 13186,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoprenaline</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a catecholamine, that can stimulate D1, D2, alpha 1 and &beta;-1 receptors, but not &beta;-2 receptors? </span></span></p>",
    "unique_key": "Q1403857",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672852,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Dopamine </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dopamine</strong> is a<strong> catecholamine neurotransmitter and hormone </strong>that exhibits activity on<strong> both dopaminergic and adrenergic receptors.</strong> It specifically<strong> stimulates D1 and D2 dopamine receptors</strong>, which are primarily involved in <strong>neurological functions </strong>and <strong>renal vasodilation</strong>, and <strong>&alpha;1 and &beta;1 adrenergic receptors,</strong> which mediate <strong>vasoconstriction and increase heart rate and contractility,</strong> respectively. Importantly, <strong>dopamine does not </strong>act on <strong>&beta;2 adrenergic receptors, </strong>which are mainly responsible for<strong> bronchodilation and vasodilation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/screenshot-2024-05-10-121213.jpg\" style=\"height:435px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></u></strong><u>&nbsp;</u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dopamine</strong> is the <strong>catecholamine</strong> that meets the criteria of stimulating <strong>D1, D2, &alpha;1, and &beta;1 receptors </strong>without affecting <strong>&beta;2 receptors</strong>, which is particularly relevant in treating certain <strong>cardiovascular conditions</strong> where <strong>selective receptor </strong>activation is <strong>desired</strong></span></span></span></p>",
    "correct_choice_id": 13185,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3346,
    "choices": [
      {
        "id": 13363,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carvedilol</span></span></span></p>"
      },
      {
        "id": 13364,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betaxolol</span></span></p>"
      },
      {
        "id": 13365,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxprenolol</span></span></p>"
      },
      {
        "id": 13366,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Labetalol</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are non-selective &beta;-blockers except:</span></span></span></p>",
    "unique_key": "Q1609447",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672816,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Betaxolol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the given options, <strong>Betaxolol</strong> is the <strong>beta-blocker</strong> that is <strong>cardioselective</strong>, meaning it <strong>primarily blocks</strong> <strong>beta-1 adrenergic</strong> <strong>receptors</strong> that are<strong> predominantly</strong> found in the <strong>heart</strong>. This selectivity can <strong>reduce </strong>the risk of <strong>bronchoconstriction</strong> and other side effects <strong>related to beta-2 receptor blockade.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cardioselective beta-blockers,</strong> sometimes called <strong>beta-1 selective blockers</strong>, are preferred for patients with <strong>asthma or chronic</strong> <strong>obstructive pulmonary disease (COPD) </strong>as they are<strong> less likely </strong>to cause <strong>constriction of the airways</strong>, which is mediated through <strong>beta-2</strong> <strong>receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carvedilol:</strong> A <strong>non-selective beta-blocker</strong> that also has <strong>alpha-blocking activity, </strong>used for the treatment of <strong>high blood</strong> p<strong>ressure and heart failure. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oxprenolol:</strong> A <strong>non-selective beta-blocker </strong>with <strong>intrinsic sympathomimetic activity. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Labetalol:</strong> A <strong>non-selective beta-blocker </strong>that also <strong>blocks alpha-1 receptors </strong>and is commonly used in<strong> pregnancy-induced</strong> <strong>hypertension.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Betaxolol </strong>is a <strong>cardioselective beta-blocker</strong> that selectively <strong>blocks beta-1 adrenergic receptors in the heart</strong>, while<strong> Carvedilol,</strong> <strong>Oxprenolol, and Labetalol</strong> are <strong>non-selective beta-blockers </strong>affecting <strong>both</strong> <strong>beta-1 and beta-2 adrenergic receptors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardio-selective beta blockers:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/33.jpg\" style=\"height:325px; width:300px\" /></span></strong></span></span></p>",
    "correct_choice_id": 13364,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3874,
    "choices": [
      {
        "id": 15475,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sumatriptan</span></span></span></p>"
      },
      {
        "id": 15476,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valproate</span></span></span></p>"
      },
      {
        "id": 15477,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol</span></span></p>"
      },
      {
        "id": 15478,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Topiramate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following drugs are used for prophylaxis of migraine except? </span></span></span></p>",
    "unique_key": "Q9035361",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672825,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Sumatriptan</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sumatriptan </strong>is the <strong>drug of choice for acute severe migraine</strong>, but it is not indicated for prophylaxis&rsquo;. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Sumatriptan</strong> is <strong>not used for the prophylaxis of migraine</strong> but is the <strong>drug of choice for acute severe migraine attacks</strong>. <strong>Prophylactic treatment</strong> of <strong>migraine</strong> is <strong>intended to reduce the frequency,</strong> <strong>severity,</strong> and <strong>duration of migraine episodes</strong>, which is different from treating an acute attack.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Valproate:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;This <strong>anti-epileptic drug</strong> is also used for <strong>migraine prophylaxis </strong>due to its <strong>ability to stabilize neuronal membranes</strong>. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Propranolol:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;This <strong>beta-blocker</strong> is considered the <strong>drug of choice for migraine prophylaxis</strong> as it can <strong>prevent the vasodilation</strong> that contributes to migraine headaches. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Topiramate:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;Another anti-epileptic drug that is effective in reducing the frequency of migraine headaches.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Sumatriptan </strong>is used for the <strong>treatment of acute severe migraine attacks</strong> and not for prophylaxis. For migraine prophylaxis, medications such as Valproate, Propranolol, and Topiramate are used.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drugs used in prophylaxis of migraine are:</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-110553.jpg\" style=\"height:363px; width:1000px\" /></span></span></strong></p>",
    "correct_choice_id": 15475,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3888,
    "choices": [
      {
        "id": 15531,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Buspirone:&nbsp; Agonist at 5-HT1A receptors</span></span></span></p>"
      },
      {
        "id": 15532,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyproheptadine: Blocks 5-HT2A receptors</span></span></span></p>"
      },
      {
        "id": 15533,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropisetron: 5-HT3 antagonist</span></span></span></p>"
      },
      {
        "id": 15534,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prucalopride: 5-HT1D receptor agonist</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following actions of drugs on the serotoninergic system is not correctly matched?</span></span></span></p>",
    "unique_key": "Q9480399",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672830,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Prucalopride: 5-HT1D receptor agonist</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Prucalopride </strong>is <strong>incorrectly matched as a 5-HT1D receptor agonist</strong>. In fact, <strong>prucalopride is a selective</strong>, <strong>high-affinity 5-HT4 receptor agonist</strong>. It is used <strong>primarily for the treatment of chronic idiopathic constipation</strong>, as its <strong>agonistic action on 5-HT4 receptors </strong>enhances gastrointestinal motility.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Buspirone: Agonist at 5-HT1A receptors</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - This is <strong>correctly matched</strong>. Buspirone is an anxiolytic medication that acts as a partial agonist at the 5-HT1A receptor, used primarily in the treatment of generalized anxiety disorder (GAD).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cyproheptadine: Blocks 5-HT2A receptors</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - This is <strong>correctly matched</strong>. Cyproheptadine is an antihistamine with additional anti-serotonergic properties, including blocking 5-HT2A receptors. It is used for various indications, including allergy symptoms and serotonin syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Tropisetron: 5-HT3 antagonist</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - This is <strong>correctly matched</strong>. Tropisetron is used primarily to control nausea and vomiting caused by chemotherapy or surgery, acting as an antagonist at 5-HT3 receptors.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to understand the <strong>specific actions of various drugs </strong>on the <strong>serotoninergic system</strong>, <strong>emphasizing </strong>the <strong>importance of receptor specificity </strong>in determining the <strong>therapeutic use of these medications</strong>. </span></span></p>",
    "correct_choice_id": 15534,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3290,
    "choices": [
      {
        "id": 13139,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tremors</span></span></span></p>"
      },
      {
        "id": 13140,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoglycemia</span></span></span></p>"
      },
      {
        "id": 13141,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalemia</span></span></span></p>"
      },
      {
        "id": 13142,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchodilation</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child on formoterol inhaler for treatment of bronchial asthma may exhibit all of the following features except?</span></span></span></p>",
    "unique_key": "Q9268135",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672850,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Hypoglycemia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;&beta;2 agonists</strong>, like <strong>formoterol</strong>, used as <strong>inhaled bronchodilators </strong>for the management of<strong> bronchial asthma</strong>, can cause a variety of<strong> side effects. Tremors</strong> are a common dose-related side effect due to the stimulation of<strong> &beta;2 receptors in skeletal muscle. Hypokalemia </strong>can occur with the use of<strong> &beta;2 agonists </strong>as they <strong>promote </strong>the <strong>uptake of potassium into cells</strong>, <strong>lowering the potassium concentration</strong> in the <strong>bloodstream</strong>.<strong> Bronchodilation </strong>is the intended therapeutic effect of<strong> &beta;2 agonists</strong>, resulting from the <strong>relaxation of bronchial smooth muscle</strong>. However,<strong> &beta;2 agonists do not </strong>typically cause <strong>hypoglycemia; </strong>in fact, they may <strong>increase blood glucose </strong>levels by<strong> stimulating glycogenolysis and gluconeogenesis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tremors </strong>- A known <strong>side effect </strong>due to the stimulation of<strong> &beta;2 receptors by &beta;2 agonists. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hypokalemia </strong>- Can occur as <strong>&beta;2 agonists </strong>increase<strong> intracellular potassium uptake</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> &nbsp;<strong>Bronchodilation </strong>- The primary therapeutic action of<strong> formoterol in bronchial asthma</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Formoterol, a &beta;2 agonist, does not </strong>cause <strong>hypoglycemia</strong>. Instead, it can cause side effects such as<strong> tremors, hypokalemia </strong>due to <strong>increased potassium uptake into cells</strong>, and the desired effect of <strong>bronchodilation </strong>for the management of<strong> asthma.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
    "correct_choice_id": 13140,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3320,
    "choices": [
      {
        "id": 13259,
        "text": "<p style=\"margin-right:-1px\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphine</span></span></p>"
      },
      {
        "id": 13260,
        "text": "<p style=\"margin-right:-1px\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Quinine </span></span></p>"
      },
      {
        "id": 13261,
        "text": "<p style=\"margin-right:-1px\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine </span></span></p>"
      },
      {
        "id": 13262,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Digoxin</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After eating a plant as shown in the figure below, A child presented to emergency in comatose state. The pupils were dilated, and skin was dry. Body temperature is raised, and heart rate is high. These signs and symptoms can occur with the intake of which of the following substance?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/picture3_XXE4pf8.jpg\" style=\"height:182px; width:300px\" /></span></span></p>",
    "unique_key": "Q5170375",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672860,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Atropine </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>signs and symptoms</strong> described are characteristic of <strong>atropine poisoning,</strong> which include <strong>dilated pupils (mydriasis), dry skin,</strong> <strong>elevated body temperature (hyperthermia), and tachycardia.</strong> The <strong>plant </strong>identified as the <strong>source of atropine</strong> in this case is <strong>Datura</strong> <strong>stramonium.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. &nbsp;Morphine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>- Incorrect,</strong> as morphine typically causes <strong>constricted pupils (miosis), </strong>not dilation. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Quinine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Incorrect,</strong> as quinine is <strong>not</strong> commonly associated with <strong>these symptoms. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. &nbsp;Digoxin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> -<strong> Incorrect, </strong>as <strong>digoxin overdose</strong> typically <strong>does not cause hyperthermia</strong> and <strong>dry skin</strong> but can cause other symptoms such as <strong>nausea, vomiting, and heart rhythm disturbances.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> DHATURA acronym</strong> can be used to remember the<strong> signs of atropine poisoning: Dry mouth and Delirium, Hyperthermia, Agitation, Tachycardia, Urinary retention, Retention of stool, and lost Accommodation (dilated pupils, photophobia, blurred vision).</strong></span></span></span></p>",
    "correct_choice_id": 13261,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3919,
    "choices": [
      {
        "id": 15655,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diclofenac </span></span></span></p>"
      },
      {
        "id": 15656,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indomethacin </span></span></span></p>"
      },
      {
        "id": 15657,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Naproxen </span></span></span></p>"
      },
      {
        "id": 15658,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetaminophen </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old female with renal disease was admitted for pyelolithotomy. Postoperative analgesic of choice in this patient is? </span></span></p>",
    "unique_key": "Q2632161",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672844,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Acetaminophen</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D:</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Acetaminophen</strong>, also known as <strong>paracetamol</strong>, is the preferred <strong>analgesic </strong>for patients with <strong>renal disease </strong>because it has <strong>minimal nephrotoxic effects </strong>compared to <strong>NSAIDs such as diclofenac</strong>, <strong>indomethacin</strong>, and <strong>naproxen</strong>. <strong>NSAIDs </strong>can <strong>impair renal function </strong>by <strong>inhibiting prostaglandins </strong>that <strong>maintain renal blood flow</strong>. <strong>Acetaminophen</strong>, which <strong>lacks significant anti-inflammatory properties</strong>, <strong>does not inhibit prostaglandins </strong>in the <strong>kidneys </strong>as extensively as NSAIDs, making it a safer option for managing pain in patients with existing renal impairment.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong><u> </u></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Diclofenac</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: <strong>NSAID </strong>with <strong>potential nephrotoxic effects</strong>, especially harmful in patients with renal impairment. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Indomethacin</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: &nbsp;Another <strong>NSAID </strong>that can <strong>affect renal prostaglandin production </strong>and impair renal function. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Naproxen: </span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp;Also an <strong>NSAID </strong>that may <strong>exacerbate renal issues </strong>due to its <strong>effect on renal blood flow </strong>and <strong>prostaglandin synthesis</strong>.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The objective is to recognize the <strong>appropriate postoperative analgesic </strong>in patients with <strong>renal disease</strong>. <strong>Acetaminophen </strong>is generally considered <strong>safe for renal patients</strong>, as it provides <strong>effective pain relief without the renal risks </strong>associated with <strong>NSAIDs</strong>. This knowledge is important for preventing potential renal complications in patients with compromised kidney function.</span></span></span></p>",
    "correct_choice_id": 15658,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3901,
    "choices": [
      {
        "id": 15583,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Xanthine oxidase</span></span></span></p>"
      },
      {
        "id": 15584,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IMP dehydrogenase</span></span></span></p>"
      },
      {
        "id": 15585,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenosine deaminase</span></span></span></p>"
      },
      {
        "id": 15586,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urate oxidase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rasburicase is an analogue of:</span></span></span></p>",
    "unique_key": "Q1606495",
    "question_audio": null,
    "question_video": null,
    "map_id": 33672834,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Urate oxidase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Rasburicase </strong>is an <strong>enzyme </strong>that <strong>acts as a recombinant version of urate oxidase</strong>, an <strong>enzyme that catalyzes the oxidation </strong>of <strong>uric acid to allantoin</strong>, which is <strong>more soluble </strong>and easily <strong>excreted by the kidneys</strong>. This <strong>mechanism makes rasburicase </strong>an <strong>effective treatment for preventing </strong>or <strong>reducing hyperuricemia </strong>(high levels of uric acid in the blood) associated with <strong>tumor lysis syndrome</strong>, which can occur after the initiation of cancer treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational goal is to understand the <strong>mechanism of action of rasburicase </strong>and its <strong>role in the management of hyperuricemia</strong>, particularly in the context of <strong>tumor lysis syndrome</strong>. Recognizing <strong>rasburicase </strong>as a <strong>urate oxidase analogue </strong>helps in <strong>understanding its utility </strong>in <strong>converting uric acid to allantoin</strong>, thus facilitating its excretion and preventing the complications of high uric acid levels.</span></span></span></p>",
    "correct_choice_id": 15586,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = '00253 Mid Day Module (Pharma-2)';
        const quizFilename = '00253-mid-day-module-pharma-2-eb5c337e.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Mid Day Module"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>